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Abstract
Book Overview:
The retinal pigment epithelium is a critical tissue within the eye. It lies directly behind the retina, where it
provides metabolic support to the photoreceptors and controls their local environment. As a result, the RPE is
vital to retinal function, but also a site of aging and disease that cause dysfunction and visual loss. This book
brings together comprehensive reviews of basic and clinical science concerning the RPE. It is organized to
juxtapose chapters on RPE disease with chapters on the underlying pathophysiology. These include up-to-
date accounts of growth factors, laser effects, proliferative vitreoretinopathy, Bruch's membrane pathology, as
well as new diagnostic tools such as ocular coherence tomography, in vivo imaging of lipofuscin and non-
photic electrical responses. Other chapters cover pharmacology and toxicology, mechanisms of retinal
adhesion and detachment, RPE pigments and transport, congenital and dystrophic diseases, animal models of
RPE disease, and different aspects of age-related macular degeneration. The history and evolutionary aspects
of the RPE are also presented. The contributing authors are experienced clinicians and eminent basic
scientists who work on this critical part of the eye. The book will be a valuable resource for anyone interested
in the eye, and a necessity for specialists in the fields of retinal physiology and retinal disease.
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14. Diseases of the retinal pigment 
epithelium-photoreceptor complex 
in nonrodent animal models 
GUSTAVO D. AGUIRRE, JHARNA RAY AND LAWRENCE E. STRAMM 
The retinal pigment epithelium (RPE) is strategically sit-
uated between the photoreceptor cells and the choroid 
to mediate a number of activities which are essential for 
normal photoreceptor function and viability. Tradition-
ally, these activities are considered to involve retinoid 
transport, esterification and isomerization, the phago-
cytosis and degradation of shed outer segments, and the 
regulation of ion and metabolite transport. Additional-
ly, evidence for the critical role played by the RPE in sus-
taining the visual cells has been supported by studies 
carried out in the Royal College of Surgeons (RCS) 
strain of retinal-dystrophic rats. In these animals, post-
natal retinal development is initially normal, but degen-
eration begins soon after photoreceptor cells have dif-
ferentiated normally. Disease occurs because the mutant 
RPE is unable to internalize and degrade the outer seg-
ment membranes that are discarded on a daily basis 
from the distal tips of the photoreceptors (Herron et aL, 
1969). This material appears as whorls of membranes 
whose accumulation in the interphotoreceptor space 
presages the degeneration and death of the visual cells. 
Elegant studies by Mullen and LaVail (1976) have es-
tablished that the target tissue for mutati~n is the RPE 
and not the photoreceptors, and the phagocytic defect 
can be examined in cell (Edwards and Szarnier, 1977) or 
organ (Tarnai and O'Brien, 1979) culture, and the pho-
toreceptor disease prevented by the transplantation of 
genetically normal RPE cells (Li and Turner, 1988). 
These and other studies carried out over the past 
twenty years have identified the critical photoreceptor-
supportive roles played by the RPE. It has been estab-
lished that primary dysfunction in the RPE can result in 
visual cell pathology and cell loss. Similarly, abnormal-
ities in the photoreceptor cells can elicit a pathologic re-
sponse in the RPE, either very early in the disease 
process or late, once the photoreceptor cells have de-
generated and disappeared. In other cases, however, the 
RPE plays a passive role, demonstrating minimal re-
sponse to the very severe disease that is occurring in its 
surround. An explanation for the varied repertoire of 
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disease and responsiveness demonstrated by the RPE 
lies in its complexity and varied functional roles. The 
RPE can no longer be considered a simple epithelial 
monolayer with uniform function and behavior. In-
stead, it must be regarded as a highly complex cell 
whose cytologic and functional properties are deter-
mined or modified by positional and topographic fac-
tors. This chapter examines the role of the RPE in dis-
eases of the pigment epithelial-photoreceptor complex 
in selected domestic animal species. In some cases, the 
diseases occur sporadically in animals, but the RPE re-
sponse is so unique that it provides insights into RPE bi-
ology or pathology. In other cases, the diseases, which 
were once identified as naturally occurring primarily in 
the dog and cat, are now maintained in laboratory col-
onies. As a result, the models have the same gene defect 
and demonstrate a consistent disease phenotype that 
lends itself readily to experimental study and analysis. 
NORMAL ANATOMY 
The histology of the RPE of domestic animals is influ-
enced by its relationship to the tapetum lucidurn, a 
choroidal modification that is located between the large 
choroidal vessels and the choriocapillaris. In dog and 
cat, the tapetum consists of rows of multilayered, flat, 
often irregularly shaped cells (tapetum cellulosurn; Fig. 
14-1 ). Ultrastructurally, the cytoplasm of the tapetal 
cells contains groups of elongated membrane-bound 
rods that are electron -dense, are oriented parallel to 
each other, and are uniform in size and spacing. The 
rods are separated from each other by amorphous 
ground substance, and by very fine fibrils and filaments. 
Within each cell, there are several groups of rods, each 
group having its own characteristic and independent 
orientation (Bernstein and Pease 1959). However, the 
rods are all arranged in a plane parallel to the pigment 
epithelial basement membrane (Fig. 14-2). 
Differences in tapetal structure, organization, and 
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FIGURE 14-1. Anatomic relationship of the tapetum lucidum (TL), 
retinal pigment epithelium, and photoreceptor cells in the posterior 
pole of the dog eye. The outer retina is nourished by arterioles from 
the choroid (open star, left) which penetrate through the tapetum and 
spread horizontally between the tapetum and retinal pigment epithe-
lium to form the choriocapillaris. Magnification X6.50. 
composition have been noted in the past by several in-
vestigators, and these differences appear to be species 
specific (see Pirie, 1966 for review). Recent studies have 
examined the tapetum lucidum in the dog and cat (Bus-
sow, 1980; Burns et al., 1988; Wen et al., 1985) and 
found that, although superficially similar in the two 
species, there are many differences in structure, cell 
number, and chemical composition (Table 14-1). Unlike 
in the dog, the tapetal rodlets in the cat retain an elec-
tron-dense core after fixation, and have a single ring 
rather than concentric rings of zinc deposition, as visu-
alized with a sulfide-silver histochemical method (Wen 
eta!., 1982; 1985). The peripheral rather than internal 
distribution of zinc around the tapetal rodlets of the cat 
may account for the tenfold-lower concentration of this 
divalent cation in the tapetum in comparison to the dog. 
In the latter species, the zinc is complexed to cysteine, 
which occurs in higher concentration in the dog tape-
tum than in any other tissue (Wen eta!., 1982). 
In contrast to carnivores, herbivores have a fibrous 
tapetum (tapetum fibrosum), consisting of bundles of 
undulating collagenous fibers arranged somewhat con-
centrically and with an iridescent surface. Except for an 
occasional fibrocyte, the fibrous tapetum is basically 
FIGURE 14-2. The tapetum lucidum (TL) consists of a multilayer of flattened cells. Each cell contains 
groups of membrane bound rods oriented parallel the basement membrane of the retinal pigment epithe-
lium. Note the prominent choriocapillaris layer (star}. In the tapetal zone, the pigment epithelium is not 
pigmented; the cytoplasmic granules are lipofuscin. Magnification X.5,800. 
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TABLE 14-1. Comparison of the morphological and 
histochemical of the mature tapetum 
lucidum the and cat 
Parameters Dog Cat 
Number of tapetal cell layers 9-11 16-20 
(central) 
Thickness of central tapetum 26-33 ~m 61-67 ~m 
Thickness of retina from the 151-184 IJ.m 145-150 IJ.m 
area of center tapetum 
Presence of a microtubule-like present absent 
structure in each tapetal rod 
Presence of electron-dense cores absent present 
in tapetal rods after prolonged 
glutaraldehyde fixation 
Distribution pattern of zinc two concentric one outer 
in tapetal rod rings nng 
Zinc in tapetum (PPM) 26,000 1,100 1,497 ::t:: 152 
in tapetum 241 ::t:: 18 0 
tissue) (n "' 6-8) 
Modified from Wen eta!., 1982; 1985 
acellular (Bellairs et al., 197 5 ). In the cow, this layer can 
be up to 50 tJ..m thick, with the collagenous bundles ori-
ented in a plane parallel to the RPE basement membrane 
(Nakaizumi 1964). Pig, rabbit, rat, guinea pig, and most 
higher primates lack a tapetum. 
Blood supply to the RPE and outer retinal layer in the 
tapetal regions is derived from the large choroidal ves-
sels external to the tapetum. Smaller vessels penetrate 
this layer and branch extensively under the tapetum, 
forming an incomplete choriocapillaris layer. In the dog 
and cat, the choriocapillaris forms a thin vascular zone 
interposed between the tapetal cells and the basal sur-
face of the RPE. Occasionally, however, deep invagina-
tions of the choriocapillaris into the basal RPE.are seen. 
In the nontapetal regions, the choriocapillaris is adja-
cent to the larger choroidal vessels. In both tapetal and 
nontapetal regions, there are multiple fenestrations in 
the thin endothelial wall of the choriocapillaris adjacent 
to the RPE. 
Unlike the human, the dog and cat lack a well-defined 
Bruch's membrane. The RPE and choriocapillaris base-
ment membranes are apposed, with infrequent collage-
nous and elastic fibers present between the two. In the 
intercapillary space of the tapetal and nontapetal re-
gions, more collagenous and elastic fibers are present, 
and a more classical Bruch's membrane is occasionally 
recognized. Of all the domestic species, the pig has the 
most prominent Bruch's membrane (Prince et al., 1960). 
The topographic variation in tapetal distribution is 
reflected in the differing cytologic characteristics of the 
RPE. The most obvious of these is the presence of 
melanin granules. Melanin is absent in areas overlying 
the tapetum, although sparse pigmentation begins to ap-
pear in junctional zones, either centrally or peripheral-
ly. In these areas, the tapetal thickness gradually de-
creases to one or two cells, and melanin granules are 
present. As the tapetal cells disappear, the degree of pig-
mentation increases. In general, RPE cells are smaller 
and have less-dense pigmentation in the posterior pole, 
and increase both in size and in extent of melanin pig-
mentation peripherally. The topographic distribution of 
pigmentation in relation to the tapetum is illustrated in 
Figure 14-3. However, the elegant studies of the human 
RPE, which examine the cell number and size, and the 
degree of pigmentation and lipofuscin accumulation in 
relation to age and topographic position have not been 
done in nonprimate species (see Dorey eta!., 1989;. Gao 
eta!., 1992; Feeney-Burns and Ellersieck, 1985; Feeney-
Burns et al., 19 84). This limitation interferes with stud~ 
ies examining disease processes in the RPE-photorecep-
tor interface. 
THE RPE IN DISEASES OF THE TAPETUM LUCIDUM 
Hereditary Diseases 
Hereditary abnormalities of the tapetum lucidum have 
been described in beagle dogs (Bellhorn et al., 1975; 
Burns et aL, 1988) and Siamese cats (Wen et al., 1982; 
Collier et al., 1985a). In dogs, the disease is autosomal 
recessive, and affected animals lack the normal tapetal 
reflex visible on ophthalmoscopy; instead, the fundus 
has a uniform red appearance without the topographic 
separation of tapetal and non tapetal zones (Burns et al., 
1988) (Plates 14-1, 14-2). Unlike the albino fundus, 
where the lack of RPE and choroidal pigmentation per-
mit visualization of the choroidal vasculature overlying 
the white sclera (Plate 14-III), dogs with the hereditary 
tapetal defect have a light, uniform choroidal pigmen-
tation which precludes visualization of the choroidal 
vessels. With the exception of the foveomacular region, 
which is not present in nonprimate species, the fundus 
appearance is quite similar to that of a lightly pigment-
ed human. 
In affected dogs, there are normal numbers of tapetal 
cells at birth, but, with time, there is a progressive de-
generation of this layer; in adult animals, the remaining 
layer of dysmorphic tapetal cells is only 1-2 cells thick 
(Fig. 14-4; Burns et al., 1988). Ultrastructural disease is 
evident in cells as early as 46 days after birth by the loss 
of the normal complement of tapetal rodlets, and the ac· 
cumulation of cytoplasmic membranous whorls (Fig. 
14-5). At this age, the normal tapetal cells are in the 
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temporal 
FIGURE 14-3. Schematic representation of the distribution of PE pig-
mentation and the presence of the tapetum lucidum in the eye of a nor-
mal cat. For comparison with the disease (MPS VI) see Figure 14-26. 
The eye is drawn to scale based on observations of sequenrial150 f.l.ID 
fields extending from the disc to the ora serrara (curved line). Note 
that the tapetum is present primarily in the superior, nasal, and tern-
process of postnatal differentiation. By 13 weeks of age, 
the abnormal tapetal cells contain only membranous 
whorls and membrane-limited inclusions. These abnor-
malities are characteristic of the process of tapetal cell 
degeneration. Associated with the cytologic abnormali-
ties, the tapetal rodlets fail to show an identifiable zinc 
signal by X-ray microanalysis, either in very young (21 
days) or adult animals (17 months) (Burns et al., 1988). 
In spite of the severe disease that is occurring in the 
tapetal layer, the RPE remains normal, and retinal func-
tion and structure are preserved. 
Similar tapetal degenerative changes have been iden-
tified in cats with Chediak-Higashi syndrome (CHS; 
Collier et al., 1985a), and, in both diseases, there is a 
striking absence of phagocytic cells during the active 
process of tapetal cell degeneration. As in the atapetal 
beagle, tapetal cells in CHS cats develop normally dur-
Right eye 
Normal cat 
16 months of agel 
poral meridians. The pigment epithelium is not pigmented in areas 
where the tapetum is present. Key: arrows indicate the presence of 
tapetum; RPE pigmentation varies from absent (empty) to moderate 
(density present in the far periphery). (For details refer to Aguirre et 
al., 1983, from which this figure was reprinted.) 
ing the early postnatal period. However, the intracellu-
lar rods begin to degenerate by four weeks of age, and 
are completely degenerated by two months of age, a 
time by which postnatal retinal differentiation is com-
pleted (Vogel, 1970). Thereafter, the disrupted tapetal 
cells begin to degenerate, and this choroidal layer is lost 
by one year of age. 
The tapetal pathology identified in cats with CHS is 
presumably unrelated to abnormalities in the RPE, since 
these occur uniformly across the monolayer as well as 
in other tissues (Collier et al., 1984). The disease is char-
acterized by greatly enlarged cytoplasmic granules, in-
cluding melanosomes and lysosomes. In the RPE of 
young affected animals, very few melanosomes are 
present, and most of the melanin granules are giant 
sized. These giant granules are composed of several 
melanosomes and premelanosomes in different stages of 
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FIGURE 14-4. Tapetal region from beagles affected with a hereditary 
degeneration of the tapetum lucidum at different stages of the disease. 
(a) 7 days old. The tapetal cells (T) form a loose, irregular meshwork 
between the RPE and choroid (C). Vessels (V) penetrate the tapetum 
and form the choriocapillaris (CC). (b) 21 days. The tapetal layer (T) 
is more regular, and the photoreceptors (P) are differentiating. (c) 46 
maturation, and contain lysosomal and melanosomal 
components (Collier et al, 1985b). The giant granules 
appear to form by inappropriate fusion of cytqplasmic 
structures, and the hypopigmentation of the RPE likely 
results from fusion of premelanosomes and lysosomes, 
with resultant destruction of the former. In the RPE 
of older animals (>7 years), numerous variably sized 
autofluorescent inclusions accumulate which, on ultra-
structural examination, are identified as secondary lyso-
somes. Additionally, extracellular giant residual bodies 
form drusenoid accumulations beneath the basal lami-
na of the RPE. These abnormalities are associated with 
focal reactive and degenerative changes of the RPE, 
characterized as focal cells loss, detachment, and mi-
gration into the interphotoreceptor space (Collier et al., 
1986). 
Although the involvement of the lysosomal system in 
CHS is evident by the abnormal fusion of lysosomes, it 
is clear that lysosomal function is normal, at least in re-
gards to the degradation of proteoglycans associated 
days. The retma (R) and RPE are normal. The tapetal layer (T) is thin-
ner, but the remaining cells, although lightly staining, retain normal 
shape. (d) 17 months old. The tapetum (T) has almost disapp<:ared, 
but the RPE and retina (R) are normal. Bar 100 J.Lm. (Reprinted 
from Burns et al., 1988.) 
with the RPE extracellular matrices, or of glycoproteins 
internalized during phagocytosis of photoreceptor out-
er segments (see below). This has been confirmed by 
studies which demonstrate that there is little effect on 
endocytic and degradative functions, even though dis-
ease affects the late endosomes and lysosomes and may 
result in the abnormal secretion of some lysosomal en-
zymes into the media by cultured cells (Burkhardt et al., 
1993; Zhao et al., 1994). Of interest have been there-
cent complementation studies using normal fibroblasts 
and fibroblasts from CHS-affected humans, mink, and 
mice. The normal human fibroblasts complemented the 
CHS fibroblasts regardless of the species, resulting in 
restoration of normal lysosomal size and distribution; 
this finding suggests the homology between the diseases 
occurring in the different species (Perou and Kaplan, 
1993). 
The tapetal defect described in the Siamese cats is not 
a specific hereditary defect within the breed, but appears 
to be part of the overall genetic makeup of the breed. 
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FIGURE 14-5. Degenerating tapetal cell from a 46-day-old beagle with 
hereditary tapetal degeneration. The tapetal rods have degenerated 
and the cell is filled with inclusions. The membrane whorl appears to 
have originated from the rough endoplasmic reticulum, and ribosomes 
are present inside or at the outer border (arrows) of the whorl. Bar 
1 IJ.m. (Reprinted in part from Burns et al., 1988.) 
Other breed-specific characteristics reported are differ-
ences in fur and ocular pigmentation, strabismus, and 
abnormalities in the retinogeniculate and cortical pro-
jections (see Wen et al., 1982 for review). Even though 
the ophthalmoscopic appearance of the tapetum is nor-
mal in Siamese cats, microscopic abnormalities have 
been identified in some animals, and consist of weakly 
staining tapetal cells on light microscopic examinations. 
On ultrastructural examination, the abnormal cells are 
filled with irregular and disoriented tapetal rods whose 
membranes are enlarged or disrupted. The cores of the 
tapetal rods appear empty, or are filled with an electron-
dense material. These abnormalities are not present uni-
formly in all tapetal cells, but vary in different layers. 
Overall, however, disease of individual tapetal cells is 
most severe in the retinal aspect of the tapetum. Associ-
ated with the tapetal abnormality is a significant reduc-
tion in the amount of zinc in the tapetal rods (Wen et al., 
1982). The causal association between the lower levels 
of zinc and the tapetal cell degeneration is not clear at 
this time. In spite of the damage to the tapetal cells, the 
RPE remains normal (Aguirre, unpublished). 
Acquired Defects: Nutritional and Toxic Damage 
Tapetal defects in cats have been reported secondary to 
a nutritional deficiency of taurine (Wen et al., 1979). In 
affected cats there is a marked reduction in thickness as-
sociated with a decrease in cell number. Additionally, 
there is a marked disorganization of the lattice arrange-
ment of the tapetal rods. This abnormality is associated 
with a taurine-associated progressive degeneration of 
the cone and rod photoreceptors, with sparing of the 
RPE (Aguirre and Rubin, 1979: Fig. 19.23). 
The most common causes of acquired tapetal defects 
have been reported in ophthalmic toxicology studies, 
particularly of dogs, where administration of various 
compounds results in dramatic changes in the tapetum 
which are visible on ophthalmoscopy, histopathology, 
and ultrastructural examination (Figs. 14-6, 14-7). The 
prototype compound to produce this effect is the anti-
tubercular drug ethambutol. Administration of this 
compound to dogs causes a decoloration of the tapetum 
and a reversible disorientation of the tapetal rods with 
no RPE or retinal damage (Kaiser, 1963; Vogel and 
Kaiser, 1963). More-severe tapetal damage occurs in the 
dog following administration of the potent zinc chela-
tor diphenylthiocarbazone (dithizone). There is retinal 
edema, pigmentary disruption, and end-stage retinal de-
generation with intraretinal pigmentation at the higher 
doses. It appears, however, that the tapetum may play a 
protective role in ameliorating dithizone toxicity of the 
retina. In the tapetal area, dithizone causes tapetal 
necrosis while sparing the underlying RPE and retinal 
layers. In contrast, areas devoid of tapetum show severe 
RPE and retinal degeneration {Aguirre and Rubin, 
1979). Similar neuroretinal damage has been reported 
in animals without a tapetum (Budinger, 1961, Butturi-
ni et al., 1953). 
Tapetal lesions also have been reported with various 
classes of compounds, not all of which are known zinc 
chelators. For example, administration of zinc pyrid-
inethione (Cloyd et al., 1978), selected beta-adrenergic 
blocking agents (Schiavo et al., 1984 ), macrolide an-
tibiotics (Massa et al., 19 84 ), aromatase inhibitors 
(Schiavo et al., 1988), and other compounds can cause 
varying degrees of tapetal damage in the dog or cat 
(Cloyd et al., 1978). Where damage is acute and severe, 
such as with zinc pyridinethione, the necrotic changes in 
the tapetum result in damage to the penetrating tapetal 
arterioles. This causes focal lesions, presumably infarcts 
in the RPE and retina, which are evident as focal areas 
of subretinal edema and hemorrhage. When the lesions 
are more severe, there is diffuse subretinal edema, reti-
nal detachment, and blindness (Cloyd et al., 1978). In 
this case the RPE appears to be damaged secondarily by 
the severe changes occurring in the adjacent tapetal lay-
er, and displays a breakdown of the outer blood-retina 
barrier. In other cases, for instance following the ad-
ministration of an aromatase inhibitor (Schiavo et al., 
1988), tapetal damage is selective and limited to this cell 
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FIGURE 14-7. Ultrastructural appearance of tapetal degeneration in-
duced by chronic administration of a tapetotoxic compound. There is 
A loss of tapetal cells. Remaining cells have disorientation of the rodlets 
B 
FIGURE 14-6. Chronic administration of a tapetotoxic compound re-
sults in tapetal degeneration in the dog. In some areas there ·is loss of 
tapetal cells (A) and the RPE abuts rhe vascular choroid (v). In other 
areas, the few remaining tapetal cells have vacuolated inclusions (ar-
rows, B). Arrowhead indicates indentation of the normal RPE by the 
choriocapillaris. Magnification X680. 
layer; thus the RPE and retina remain normal. The dif-
ferential expression of the compound-associated dam-
age between the tapetal and nontapetal areas is intrigu-
ing, and raises concerns about the interpretation of 
tapetal lesions in animals used in toxicologic studies. 
For that reason, several studies of potentially tapeta-
toxic compounds also use atapetal dogs having the 
hereditary absence of this structure {Burns et al., 1988). 
It has been clearly demonstrated that, in contrast to the 
findings in normal dogs, these compounds cause no oc-
(*),and accumulation of vacuoles (V) and membrane whorls (open 
arrow). Magnification xtO,OOO. Compare with Figure 14-5. 
ular abnormalities in dogs lacking a tapetum (Cloyd et 
al., 1978; Massa et al., 1984; Schiavo et al., 1984). 
THE RPE IN HEREDITARY PHOTORECEPTOR DISEASES 
Hereditary diseases affecting the rods and cones, either 
primarily or secondary to an RPE defect, are recognized 
in a number of different species including man. Regard-
less of the underlying cause, the diseases appear to af-
fect the photoreceptors early and progressively; in the 
advanced stages, the entire visual cell layer is destroyed, 
and there is damage also to the inner retinal layers and 
the RPE. In man, this class of diseases is referred to, col-
lectively, as retinitis pigmentosa (RP). Multiple loci for 
RP have been recognized, but few genes have been iden-
tified {see Dryja and Li, 1995 for review). Recent stud-
ies of retinal degeneration in human patients and animal 
models have identified mutations in six different genes 
{rhodopsin, peripherin/rds, rom-1, a and [3 subunits of 
rod cyclic GMP-phosphodiesterase [PDEA and PDEB], 
and the cyclic GMP-gated channel) as causally associat-
ed with RP (Humphries et al., 1992; Kajiwara et a!., 
1991; 1994; Travis et al., 1989; Bowes et al., 1990; 
Suber et al., 1993; McLaughlin et al., 1993; Dryja eta!., 
1995; Huang et al., 1995). Some of these genes-
rhodopsin, rom-1, PDEB-are expressed exclusively in 
the rod photoreceptor cells, yet the clinical and patho-
logic phenotype of RP and related diseases indicates that 
there is progressive rod and cone degeneration with a 
late and secondary involvement of the RPE. It appears 
that all defects that cause widespread disease and de-
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generation of rods, regardless of the selective expression 
of the gene product in rods, result in the concomitant 
loss of cones, and progressive retinal degenerative dis-
ease. 
The manner in which cellular dysfunction, disease, 
and degeneration are expressed in the visual cell layer is 
dependent, to a large extent, on the gene affected and 
the nature of the mutation. However, different muta-
tions of the same gene can result in a varied clinical phe-
notype, for example with opsin (Berson et al., 1991; 
Dryja et al., 1993) and peripherin/rds (Weleber et al., 
19 9 3) genes, and factors external to the visual cell may 
also play a modulatory role to influence the temporal, 
topographic, or cellular distribution of the disease. In 
this brief overview, we discuss different aspects of pho-
toreceptor disease from the perspective of the RPE. 
Progressive Retinal AITophy {PRA} in the Dog 
The PRA class of diseases represents a heterogeneous 
grouping of retinal disorders having similar disease phe-
notype. Like RP in man, the term PRA represents an ag-
gregate of different genetic defects having a broadly sim-
ilar clinical phenotype. All show the same general 
ophthalmoscopic abnormalities (Plate 14-IV) and visu-
al deficits characterized initially by rod dysfunction fol-
lowed by loss of day vision; in the late stages of the dis-
ease, the animals are blind, have end-stage retinal 
degenerative changes, and secondary cataracts. Exclud-
ing the absence of intraretinal pigmentation, which ap-
pears to be a property unique to the human retina with 
advanced photoreceptor disease, the clinical phenotype 
of PRA in dogs is similar to RP in man. 
Within this general grouping, PRA is subdivided into 
developmental and degenerative diseases (Table 14-2). 
The developmental class represents a large grouping of 
genetically distinct disorders which are expressed cyto-
logically in the postnatal period, at the time that visual 
cells are beginning to differentiate. These developmen-
tal disorders represent a dysplasia of the rod and/or 
cone photoreceptors, and each has its own unique dis-
ease course and phenotype, as assessed by functional 
and morphologic criteria (Aguirre, 1978; Acland and 
Aguirre, 1987; Acland et al., 1989; Parshall et al., 
1991). Even though all dysplasias show rather severe 
structural alterations of the photoreceptor cells, the rate 
of progression to loss of cones, the hallmark criteria for 
loss of functional vision, is varied; e.g., this occurs ear-
ly in the erd, rcdl and rcd2 retinas, but not until the 
equivalent of middle age in pd and rd. In contrast, the 
degenerative class of diseases represents defects in which 
photoreceptor cells degenerate after having differentiat-
ed normally; this class includes diseases at the progres-
TABLE 14-2. Gene loci for hereditary photoreceptor 
diseases in 
Disease name Gene locus 
Progressive Retinal Atrophy (PRA} 
L Abnormal Photoreceptor Development 
Rod-cone dysplasia 1 rcd1 
Rod-cone dysplasia 2 rcd2 
Rod dysplasia rd 
Early retinal degeneration erd 
Photoreceptor dysplasia pd 
II. Photoreceptor Degeneration 
Progressive rod-cone 
degeneration 
X-linked PRA 
prcd 
XLPRA 
Other Primary Photoreceptor Diseases 
Cone degeneration cd 
csnb 
Genes excluded/included 
PDEB (codon 807-stop) 
PD EB, transducin cx-1 
RDS/peripherin, opsin, 
PDEB, transducin cx-1 
RDS/peripherin, opsin, 
PDEB, transducin cx-1 
Transducin 133 
Data from Aguirre and Acland, 1988; Acland et al., 1989; 1994; 
1995; Aguirre and Rubin 1974; Akhmedov et al., 1997; Ray et aL, 
1996, 1997; Wrigstad, 1994. 
sive rod-cone degeneration (prcd) and XLPRA gene loci 
(Aguirre et al., 1982a; Aguirre and Acland, 1988; 
Acland et al., 1994). Here, disease occurs more slowly, 
and is modified by temporal and topographic factors 
(see below). Different alleles have been identified at the 
prcd locus (Aguirre and Acland, 1988), and these seg-
regate independently to regulate the rate, but not the 
phenotype, of photoreceptor degeneration (Acland and 
Aguirre, unpublished). Examples are presented below. 
Photoreceptor Dysplasias, Abnormal Retinal cGMP 
Metabolism and Retinal Degeneration 
Rod-cone dysplasia 1. Rod-cone dysplasia! (rcdl) in 
the Irish setter is a recessively inherited photoreceptor 
defect characterized by arrested differentiation of visu-
al cells resulting from an abnormality in retinal cyclic 
GMP (cGMP) metabolism (Aguirre et al., 1978; 1982b). 
Beginning at ten days of age, deficient cGMP-phospho-
diesterase (cGMP-PDE) activity causes the retinal levels 
of cGMP to rise sharply to concentrations up to tenfold 
higher than normal; these biochemical abnormalities 
are present before degenerative changes are observed in 
the photoreceptor cells (Fig. 14-8). The morphologic 
and biochemical phenotype of the disease is similar to 
that present in the rd mouse (Farber and Lolley, 1974 ). 
Homology between the dog and mouse diseases, as well 
as to some forms of RP in man, has been established by 
identification of mutations in the PDE-Beta (PDEB) 
~I 
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FIGURE 14-8. Developmental pattern of changes in cGMP concentra-
tion with age in retinas from dogs affected with rcdl (Irish setter, up-
per panel) and rcd2 (collie, lower panel}. Normal values (solid circles} 
from controls are included in each figure. ln both rcdl and rcd2, lev-
els of cGMP increase early in the postnatal period to values 8-10 times 
higher than normal. (Modified from Chader et al., 1985.) 
subunit gene as being responsible for the distases in the 
three different species (McLaughlin et al., 1993; Bowes 
et al., 1990; Farber et al., 1990; 1992; Suber et a!., 
1993). Not surprisingly, human RP patients with ab-
normalities in the PDEB gene show a varied mutation 
spectrum (McLaughlin et a!., 1995). In contrast, the 
same two different abnormalities have been identified 
concurrently in all rd strains examined (Pittler and 
Baehr, 1991; Bowes et al., 1993), while all rcdl-affected 
dogs have the same mutation in codon 807 (TRP807x), 
which presumably results in the premature termination 
of the PDEB protein by49 amino acid residues (Clement 
et al., 1993; Ray et al., 1994 and 1995). 
A question arises about the specificity of the abnor-
mal retinal cyclic nucleotide metabolism, and whether it 
is limited to the visual cells. In our original study, we 
found that retinal cGMP levels were elevated in retina, 
but not in the RPE/choroid complex or in nonocular tis-
sues (Aguirre eta!., 1978). Subsequently, using the reti-
nallayer microdissection method of Lowry, Barbehenn 
and colleagues ( 1988) found that the elevated retinal 
cGMP levels are confined to the photoreceptor cells. 
Since the outer segments of the affected visual cells are 
small, and degenerate early, the elevated cGMP levels 
are not located in this structure but, rather, are present 
in the outer nuclear and plexiform layers (Barbehenn et 
al., 1988). Such abnormally high levels of cGMP in the 
synaptic terminals are unexplained, but may indicate 
aberrant sites of synthesis or trafficking of newly syn-
thesized cyclic nucleotides in the dysplastic rod pho-
toreceptors. Additionally, more recent studies indicate 
that there are no abnormalities in cyclic nucleotide lev-
els in cultured RPE cells of rcdl-affected dogs, further 
confirming the specificity of the defect to the visual cells 
(Table 14-3; Stramm, Fletcher, Aguirre, and Chader, un-
published). 
In rcdl-affected dogs, there is normal retinal structure 
and opsin biosynthesis during the first two weeks of life. 
However, at the time when photoreceptors begin to dif-
ferentiate in the normal retina (13-16 days), develop-
ment of rods in the rcdl retina is arrested, and the dis-
eased cells begin to degenerate; by 25 days after birth, 
photoreceptor cell death begins, and this process con-
tinues throughout the first year of life (Fig. 14-9) 
(Aguirre eta!., 1982b; Schmidt and Aguirre, 1985). The 
degeneration initially affects the rods, and, as these cells 
degenerate, the proportion of cones in the visual cell lay-
er increases. However, cone degeneration develops 
eventually, and results in collapse of the interphotore-
ceptor space, bringing into close apposition the apical 
surfaces of the RPE and Muller cells. In spite of the se-
vere disease that is occurring in the apposing visual cell 
layer, the RPE remains normal and minimally reactive, 
and, as is characteristic of hereditary retinal diseases in 
nonprimate models, there is a lack of intraretinal pig-
ment migration. 
Photoreceptor-RPE interactions occur through the 
interphotoreceptor matrix (IPM). Until recently, this 
matrix was ill defined, and its structural and functional 
characteristics were not clear. The IPM is now known 
to be a complex and highly ordered structure consisting 
of soluble and insoluble constituents in which proteins, 
TABLE 14-3. Cyclic nucleotide levels {picomole/mg 
protein) in primary cultures of RPE cells ten-
week-old normal, carrier, and 
Nucleotide 
cfu.\1P 
cGMP 
Normal 
3.1 ::': 1.6 
1.8 1.7 
Carrier 
3.9 ::': 2.9 
1.8 ::': 1.1 
Affected 
2.2 ::': 0.2 
1.2:!: 0 
Unpublished data from Stramm, Fletcher, Aguirre, and Chader. 
..... ____________________ _ 
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FIGURE 14-9. Retinas from normal (AH) and rcd1-affected Irish set-
ters (B1.6 ) of different ages. Normal: A1•4 = 10 days, 13 days, 26 days, 
and adult. Affected: BH = 9 days, 16 days, 33 days and 57 days; B5,6 
1 year. In the normal dog, the inner segments are distinct by 10 days, 
and outer segments have elongated to near adult proportions by 26 
days. The adult retina has a high photoreceptor density, and the rods 
outnumber the cones (arrows in A4 ). The rcdl retina shows normal 
development at 9 days of age. At 16 and 33 days of age, the rod inner 
segments have not elongated, and the outer segments are short and 
disorganized. Loss of rods results in increased prominence of cones 
(arrows in B3.4), and thinning of the ourer nuclear layer. By 1 year of 
age, photoreceptor loss is extensive. At all stages of the disease, the 
RPE is normal. Magnification X400. (Reprinted from Farber et al., 
1992.) 
glycoproteins, enzymes (acid hydrolases, etc.), glycosam-
inoglycans (GAGs), proteoglycans, and other molecules 
are localized (see Hageman and Johnson, 1991 for re-
view). Within the insoluble matrix, individual rods and 
cones are invested by photoreceptor type specific do-
mains (Hageman and Johnson, 1991; Mieziewska et al., 
1991 ). A matrix disorder that affects either its synthesis 
or maintenance could adversely affect these two cell lay-
ers; alternatively, disease in the photoreceptors or RPE 
layers could induce secondary changes in the matrix 
structure to modify the rate of visual cell degeneration. 
The complexity of the IPM and the various cell types 
that border the matrix (rods, cones, RPE, and Muller 
cells) precludes establishing a cell-specific association 
between a given component and a cell. Similarly, the 
contribution of different cell classes to the development 
of the matrix is also not known. Because of the severe 
developmental arrest that occurs in rcdl-affected pho-
toreceptors, we have examined the matrix to see if ab-
normalities in photoreceptor differentiation affect the 
development or maintenance of the insoluble IPM 
(Mieziewska et al., 1993a). The insoluble matrix do-
mains of the IPM are characterized using lectin cyto-
chemistry (wheat germ agglutinin [WGA] and peanut 
agglutinin [PNA] lectins) in cryosections of retinal tis-
sues and in extracted insoluble matrix preparations, and 
examined by epifluorescence and scanning confocal 
laser microscopy. 
In the normals, the insoluble matrix is extracted as a 
continuous sheet that comprises two photoreceptor-
specific matrix domains distinguished both by the size 
of the domains, and by differential binding ofWGA and 
PNA lectins (Mieziewska et al, 1991). Each domain en-
closes a photoreceptor inner and outer segment. The 
PNA lectin primarily labels galactose residues in the 
cone-associated matrix, with weak binding to the rod 
matrix; the WGA lectin labels equally the rod- and 
cone-associated matrices which contain N-acetyl glu-
cosamine and sialic acid residues. The specific matrix 
domains identified with these lectins are present early in 
the postnatal developmental period, at the time that the 
two classes of photoreceptors are recognizable cytolog-
ically, and they mature in parallel with visual cell mor-
phogenesis. Since the matrix conforms to the shape of 
the individual rods and cones it surrounds, the struc-
tural changes associated with normal photoreceptor de-
velopment also occur in the matrix (Fig. 14-10A1,2 ) (Mieziewska eta!., 1993a). 
As noted previously, the rcd1 retina shows normal de-
velopment of the photoreceptors during the first two 
weeks of life, and during this time period the IPM also 
develops normally. However, no change in matrix struc-
ture or carbohydrate specificity is found during the pe-
riod of developmental arrest (13-24 days postnatal), or 
after the onset of photoreceptor degeneration (after 25 
days of age; Schmidt and Aguirre, 1985). The only 
changes in the IPM that occur during this time are con-
formational, i.e. distortion, adherence of cellular debris, 
and loss of continuity, abnormalities that are presum-
ably secondary to the severe pathology occurring in the 
visual cells within the individual domains. These occur 
in older affected retinas as the abnormally developed 
outer segments disappear and the inner segments short-
en and broaden concomitant with cell loss in the pho-
toreceptor layer (Fig. 14-1 OB1_4 , C1,2 ). Survival of cones 
late in the disease is a feature of rcdl, and PNA labeled 
cone domains remain intact, even when surrounding 
severely degenerated cone cells (Mieziewska et al., 
1993a). 
The cellular origin of the matrix constituents has not 
been established (Mieziewska, 1993). Due to the close 
relationship between matrix and photoreceptor cells in 
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FIGURE 14-10. Optical sections normal and rcdl-affected retinas 
viewed with a confocal scanning laser microscope. Sections were col-
lected in 0.5 j.l.m increments, and each picture represents one section. 
Normal retina 60 days old shows the distribution of PNA (A 1) and 
WGA (A2 ) label in both rod and cone matrices. A substructure of the 
cone matrix is labeled by both PNA and WGA (arrow). The WGA ma-
trix label is stronger in the OS layer than in the IS layer. In the 40-day-
old rcd1-affected retina (B 1,3 = PNA, central [1] and peripheral [3] 
normal and diseased retinas, it is reasonable to assume 
that the photoreceptor cell is synthesizing its own ma-
trix domain. Studies have shown that photoreceptors 
are likely to synthesize chondroitin sulfate proteogly-
cans which are parts of the insoluble matrix (Landers et 
al., 1991). However, the close association between pho-
toreceptor cells, matrix, and RPE does not preclude the 
involvement of RPE in synthesis of specific matrix com-
retina; B1 ,4 WGA, central [2) and peripheral [4) retina) the CIS ap-
pear to be displaced sclerally in relation to the small RIS. At 60 days 
(Cl = PNA, C2 WGA) substantial cell loss has occurred and the 
cone inner segments are close to the OLM (arrowhead), but label 
specificity is comparable to the normal retina (C 1). The WGA lectin 
labels a domain that is irregular and distorted secondary to the rod 
disease (C,). Magnification X1200. (Reprinted from Mieziewska et 
a!., 1993a~) 
ponents, either directly or via inductive factors. The 
studies with the rcdl mutant show that normal pho-
toreceptor development is not a prerequisite for the in-
soluble IPM to develop normally. Similarly, normal 
maintenance of the matrix occurs even when the visual 
cells are undergoing very rapid and severe degeneration, 
and the matrix disappears only after there is photore-
ceptor loss. It is possible, therefore, that the RPE and/or 
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Muller cells are the principal cells involved in maintain-
ing this elaborate and complex extracellular scaffold 
once it is synthesized. Alternatively, one could argue 
that the photoreceptor cells, although severely diseased, 
still are able to orchestrate the formation of the insolu-
ble IPM, and this structure is maintained normally un-
til the visual cells disappear. These are issues that can-
not be resolved at present. What is known, however, is 
that the RPE plays a critical role in the remodeling and 
degradation of matrix constituents through the extra-
cellular and intracellular pathways involved in the 
degradation of the GAG components of matrix proteo-
glycans. This will be discussed in subsequent sections 
(see below). 
Rod-cone dysplasia 2. A second early-onset photore-
ceptor dysplasia has been identified which appears to 
share many phenotypic similarities with rcd1, and, as a 
result, has been given the disease designation of rod-
cone dysplasia 2 (rcd2) to differentiate it from the dis-
ease present in the Irish setter dogs. Based on clinical, 
electrophysiological, morphological, and biochemical 
criteria, the two diseases are identical ( Chader, 1991; 
Woodford et al., 1982). In both, there is an equally rapid 
increase in retinal cGMP levels early in the postnatal pe-
riod; the magnitude of this elevation, as well as its time 
course, are the same (Fig. 14-8). In both rcdl and rcd2 
there also is deficient cGMP-PDE activity, although in 
the latter the activity is calmodulin independent (Chad-
er et al., 1985; Chader, 1991). As in rcdl, the disease is 
expressed initially in the photoreceptor cells, and there 
is sparing of the RPE and inner retinal layers until the 
end-stages of the disease. 
Although rcdl and rcd2 are phenotypically and bio-
chemically identical, there is considerable evidence that 
the disorders represent mutations of different genes. 
With the advent of a molecular diagnosis for rcdl, we 
have established that this mutation is not present in 
rcd2, and that the nucleotide sequence of exon 21 of the 
PDEB gene in rcd2-affected dogs is normal (Ray et al., 
1994). This finding does not by itself rule out the PDEB 
gene involvement in rcd2, as a different mutation may 
be present elsewhere in the coding sequence, in an in-
tron-exon junction or in the promoter or a regulatory 
region. The most compelling evidence for nonidentity of 
the two diseases comes from our group's previous work 
in which they performed crosses between dogs affected 
with rcdl and rcd2 arid found the progeny to be normal 
(Acland et al., 1989). Thus rcd1 and rcd2 represent non-
allelic diseases that have similar effects on retinal cyclic 
GMP metabolism. It is likely, therefore, that the molec-
ular defect in rcd2 resides in one of the two remaining 
PDE subunits, or in the genes coding for proteins in-
volved in PDE activation. 
Other photoreceptor dysplasias. Table 14-2 summa-
rizes the developmental and degenerative photoreceptor 
diseases of the dog. Two of these, rcd1 and rcd2 have 
been discussed above. Of the three remaining diseases, 
the mutant strain for one, rod dysplasia (rd), has been 
lost, and the disease is no longer extant in the general 
population, nor is it maintained in experimental re-
search colonies (Aguirre, 1978; Acland and Aguirre, 
1987). In all of these diseases there is a minimal RPE re-
sponse to the degenerative process occurring in the ad-
jacent photoreceptor layer (Fig. 14-11). It is only in the 
late stages of the disease that the RPE undergoes atro-
phy and limited intraretinal migration into areas that 
are gliotic and disorganized (Fig. 14-12). These reac-
tions are secondary and nonspecific. Of interest is the 
exclusion of abnormalities in retinal cyclic nucleotide 
metabolism as being causally associated with the dis-
eases. This has been done biochemically in the case of 
pd and erd (Acland et al., 1989; Parshall et al., 1991). 
In the latter disease, mutations in the PDEB gene have 
been excluded, respectively, by breeding and molecular 
studies (Acland et a!., 1989; Ray et a!., 1994). This es-
tablishes that abnormalities in retinal cGMP metabo-
lism in the retina are not the only causes of photorecep-
tor dysplasias, although they are likely to be involved in 
those diseases that have an early onset and a relatively 
rapid disease course. 
FIGURE 14-11. Muller fiber baskets (arrows) projecting through the 
external limiting membrane (EL\1) become prominent after loss of 
photoreceptor cells in rd-affected retina. Inset shows the reduction in 
photoreceptor number and the shortening of rod inner segments (Rl). 
The RPE is normal. Magnifications: X17,000 for main figure, X200 
for inset. (Reprinted from Aguirre, 1978.) 
272 INHERITED AND METABOLIC DISORDERS 
FIGURE 14-12. Different stages of disease in rd illustrate the RPE re-
sponse to the photoreceptor degeneration. (A) In a high-cone-density 
area of the posterior pole, the loss of rods results in increased promi-
nence of cones. The RPE is normal. (B) An isolated segment of RPE 
and outer nuclear layer remain. (C) Focal retinal gliosis with loss of 
retinal layer organization; the RPE is normal. (D) End stage atrophy. 
The RPE is absent to the left of atrophic focus, but is present to the 
right and has migrated intraretinally (arrow). Magnifications: (A) 
X370; (B) XlOO; (C) X200; (D) X170. (Reprinted from Aguirre, 
1978.) 
Photoreceptor degenerations. Of the degenerative group 
of hereditary retinal diseases, mutations at the prcd gene 
locus account for all of the autosomal disorders recog-
nized to date (Aguirre and Acland, 1988; 1991; unpub-
lished). The prcd gene, as well as the different mutations 
responsible for the defined allelic variants, has yet to be 
identified. However, very recent studies in our lab have 
excluded the peripherin/rds, opsin, PDEB rod trans-
ducin a1 genes from the prcd gene locus (Acland et al., 
1995; Wang et al., 1995; Ray et aL, 1996; 1997). Thus, 
prcd may represent a mutation of one of the other genes 
or gene loci that have been identified to cause RP, or, al-
ternatively, of a novel gene not previously associated 
with the disease. 
Photoreceptor disease and degeneration-temporal and 
topographic factors. As a degenerative disease of the vi-
sual cells, structural and functional abnormalities in 
prcd become evident after the cells have developed nor-
mally. Pathology occurs first in the rod outer segments, 
and progresses, with time, to involve the inner segments, 
and the inner retinal layers. This highly characteristic 
sequence of disease has allowed us to stage the struc-
tural abnormalities into three major phases: a-disease 
(stages 1 *-1); b-degeneration (stages 2-4); c-atrophy 
(stages 5-8) (Fig. 14-13; Aguirre and Acland, 1988; 
Long and Aguirre, 1991). Starting at approximately 
12-14 weeks of age, all photoreceptor cells begin to de-
velop the stage-specific pathology characteristic of the 
disease, but the rate of progression is dependent on 
topographic factors (Aguirre et al., 1982a). In all cases, 
pathology is more severe in the inferior quadrants, while 
the visual cells in the superior and temporal retinal 
quadrants are spared the ravages of the disease until lat-
er (Fig. 14-14). Throughout the three phases of the dis-
ease, the RPE remains normal and minimally reactive 
(Fig. 14-13 ). Only in very advanced disease will the RPE 
show the nonspecific atrophic and migratory responses 
illustrated in Figure 14-120. An additional complexity 
is the selectivity of the disease, at least initially, for rods. 
Cone pathology develops late, after rods have begun to 
degenerate (stage 2 and later). With loss of rods, the 
cones become the predominant cell remaining in the 
photoreceptor layer (Fig. 14-15). 
This topographic distribution of disease is not unique 
to prcd, but occurs also in other retinal degenerations, 
particularly in man. The inferior retina appears to be se-
lectively affected in some forms of RP regardless of the 
molecular basis of the disease. Different rhodopsin mu-
tations have been causally associated with RP, e.g. 
Pro23His and Gly106Arg (Heckenlively et al., 1991; 
Fishman et al., 1992), although not all patients with the 
same molecular defect show the same regionally selec-
tive damage to the inferior retina (compare Berson et al., 
1991 and Heckenlively et al., 1991). The identification 
of the factors that modify the topographic expression of 
the photoreceptor pathology would provide important 
information on the interaction between the molecular 
defect, the visual cell, and the local retinal environment, 
and provide insights of the regulation of the disease phe-
notype. In order to identify such factors, we have ex-
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FIGURE 14-13. Disease stages in prcd: S-0 (A), S-1 *(B), S-1 (C), S-2 
(D), S-3 (E), S-4 (F), S-5 (G), S-6 (H), S-7 (I) and S-8 (]).Arrowhead 
(F) indicated RPE process contacting the external limiting membrane; 
,. (H, I, J) indicate RPE; arrow (1) indicates retinal vessel. At all stages 
of the disease, the RPE remains structurally normal. Magnification 
X430. (For details refer to Aguirre and Acland, 1988, from which this 
figure was reprinted with permission.) 
amined several different parameters that could be in-
volved in modulating the rate and severity of the pho-
toreceptor degeneration. These include: RPE pigmenta-
tion (Aguirre and O'Brien, 1986), invasion of 
pha-gocytic cells into the interphotoreceptor space 
(Aguirre, 1986), visual cell renewal (Aguirre and 
O'Brien, 1986), the soluble and insoluble components 
of the IPM (Wiggert et al., 1991; Mieziewska et al., 
1993b), and the expression of photoreceptor-specific 
proteins and transcripts (Huang et al., 1994). Thus far, 
no specific properties have been identified in the inferi-
or retinal quadrant that selectively predisposes this area 
to earlier and more severe disease. Some of these issues 
are addressed below. 
Photoreceptor degeneration, RPE pigmentation and in-
terphotoreceplor space phagocytic cells. As noted in the 
section on "Normal Anatomy," above, the dog RPE is 
not pigmented in the tapetal region (Fig. 14-1 ). Addi-
tionally, the density of pigmentation is also not uniform, 
with pigmentation density being greater in the periph-
ery. Because of the presence of pigmented and nonpig-
mented RPE regions overlying the photoreceptor mosa-
ic, it is essential to consider topographic effects when 
evaluating the influence of pigmentation on diseases of 
the photoreceptor-RPE complex. 
We have developed a technique for sampling retinal 
tissues from topographically defined regions of the eye 
using tissues embedded either in plastic (following glu-
taraldehyde/osmium tetroxide fixation) or in diethylene 
glycol distearate (DGD) wax after paraformaldehyde 
fixation (Aguirre et al., 1983; 1986; Huang eta!., 1993 ). 
This permits cutting 1 1-1m sections which extend from 
the optic disc to the ora serrata in all four quadrants; the 
tissue can then be examined by conventional light mi-
croscopy after staining (plastic sections), or following 
FIGURE 14-14. Variation of prcd disease severity by quadrant. All 
photographs taken 3000 11m from the edge of the optic disc in the su-
perior (Al' B1, C1 ), inferior (A2 , B2, C2 ) and temporal (A3, B3, C3 ) 
quadrants of animals at 1.1 (AH), 2.1 (B1_3 ), and 2.5 (C1_3 ) years. 
Disease progresses first in the inferior quadrant; visual cells degener-
ate, and macrophages (arrowhead) invade the interphotoreceptor 
space. Cones (arrows) are generally spared by the disease process and 
remain normal, particularly in the temporal quadrant. Magnification 
X400. (Reprinted from Aguirre and Acland, 1988.) 
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FIGURE 14-15. Stage 2 disease {prcd). There is extensive rod outer and 
inner segment degeneration and loss which results in the increased 
prominence of the cones. The RPE is normal. RN = rod nucleus, CN 
cone nucleus, EL\1 external limiting membrane. Magnification 
X4000. (Reprinted from Aguirre and O'Brien, 1986.) 
lectin, immunocytochemical and/or in situ hybridization 
procedures carried out in the same tissue. In this manner, 
it is possible to correlate disease stage with any of the pa-
rameters that are potentially involved in modulating the 
severity of the visual cell degenerative process. 
In young prcd-affected animals, the retinas show a 
central-to-peripheral gradation of disease severity (Fig. 
14-16). Early disease (stages-P, -1) is present through-
out the posterior pole and equatorial regions, but stops 
abruptly in the periphery where the photoreceptors be-
come normaL This change in disease severity could be 
associated with increasing RPE pigment density, since 
a gradual change in pigmentation also occurs in a cen-
tral-to-peripheral gradient. This finding raises the pos-
sibility of a pigmentation associated protective effect. 
However, critical examination of the areas where pig-
mentation changes abruptly reveals that the change in 
disease severity (from stage-1 to stage-0) is not associ-
ated with a change in pigmentation. Thus, the improve-
ment in disease severity appears to be dependent on 
topographic position of the visual cells in the photore-
ceptor mosaic rather than RPE pigmentation. With pro-
gression of the disease, the peripheral sparing effect is 
lost, and disease severity is of equal or greater magni-
tude to that present more centrally (Fig. 14-17). 
In fact, it could be argued that the presence and den-
sity of RPE pigmentation per se enhances the disease 
process. After all, the transition from disease (stage-1) 
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FIGURE 14-16. Illustration of the topographic distribution of retinal 
disease in rhe right eye of a 22-week-old prcd-affected dog (refer to 
Figure 14-13 for details of disease stages). The rectangles indicate the 
exact length of the section and retinal position {refer to 3000 p.m cal-
ibration marker) in relation ro the optic nerve (central circle) and ora 
serrata (curved line). Rectangles above and below the optic disc rep-
resent, respectively, the superior and inferior retinal quadrants; the 
temporal quadrant is represented by a horizontal rectangle. The de-
grees of shading within the rectangles represent the extent of RPE pig-
ment density. Note that the peripheral retina is normal, but the RPE 
pigmentation density does not ameliorate the severity of the disease. 
(Reprinted with modification from Aguirre and O'Brien, 1986.) 
to degeneration (stages-2, -3, -4) occurs first in the infe-
rior retinal quadrant, a region characterized by heavy 
pigmentation in the RPE monolayer (Fig. 14-17}. It is 
this quadrant that shows the degeneration of the pho-
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FIGURE 14-17. Comparison of the topographic distribution and pro-
gression of retinal disease in both eyes of a prcd-affected dog at two 
different ages ( 1.1 and 2.0 years). Refer to Figure 14-13 for details of 
disease stages, and to Figure 14-16 for explanation of the schematic 
illustration. At the earlier time period (1.1 years), the peripheral reti-
toreceptors and loss of 75%-80% of the outer nuclear 
layer at the time that the visual cells in other quadrants 
of the eye show minimal disease. Thus, the selectivity of 
the disease process for the inferior retinal quadrant can 
not be explained on the basis of a protective effect of 
pigmentation. These results are different from those re-
ported for the RCS rat, where light deprivation or pig-
mentation have a protective effect, and reduce the rate 
of the retinal degeneration (LaVail and Battelle, 1975; 
La Vail, 1980}. 
B. 2.0 years 
(right eye) 
-...--S-7 
-s-3 
-S-0/S-1* 
S-1/S-2 
S-0/S-1 * S-1 
S-1 
T 
S-3 S-1 S-2 
S-1/S-3 
S-2/S-3 
3000.u 
S-3 
na is normal in the superior, temporal, and nasal quadrants. With 
time, the disease progresses to involve the periphery. Note that disease 
is more severe in the inferior quadrants, and that RPE pigmentation 
does not have a protective effect. (Reprinted with modification from 
Aguirre and Adand, 1988.) 
A prominent feature of the degenerative phase of the 
disease is the presence of cells in the interphotoreceptor 
space (Fig. 14-14B2 }. Initially, we suspected that these 
cells represented activated RPE cells that had detached 
and migrated into the interphotoreceptor space. How-
ever, we found no area of the RPE monolayer that was 
devoid of RPE cells, or that showed breaks in the apical 
tight junctions that define the outer blood-retina barri-
er. Cytological examination showed that these cells like-
ly represented phagocytic rather than RPE cells, because 
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Superior 
Control 
Affected #1 
Affected #2 
14 # Phagocytic cells 
10 
Affected #3 
~-
FIGURE 14-18. l'Iisrograms correlating photoreceptor numbers {rows 
of nuclei), disease stage (refer to shading key below}, and number of 
phagocytic cells in the interphotoreceptor space for the superior, infe-
rior and temporal retinal quadrants of control and prcd-affected dogs 
at 22 weeks (#1 and 2) and 36 weeks (#3) of age. In the younger af-
fected dogs, disease is less severe in the periphery, the photoreceptor 
they lacked pigmentation and had irregularly shaped, 
pale nuclei with dense peripheral chromatin condensa-
tion (Aguirre, 1986). Recent studies in the RCS rat in-
dicate that the phagocytic cells that invade the inter-
photoreceptor space are of microglial origin (Roque et 
al., 1996). 
We have examined the association between photore-
ceptor disease and the presence of phagocytic cells in the 
interphotoreceptor space. In young affected dogs, early 
disease (stages 1 'f and 1) is present uniformly through-
out the eye, and phagocytic cells are absent. With pro-
gression to stage 2, however, phagocytic cells appear 
Inferior Temporal 
Microns x 100 
number remains within normal limits, and phagocytic cells are not 
present. The older affected dog (#3) shows more advanced disease (S-
2), especially in the inferior quadrant. Phagocytic cells are present in 
the interphotoreceptor space, primarily in areas of S-2 disease. 
(Reprinted with modification from Aguirre and O'Brien, 1986, and 
Aguirre, 1986.) 
(Fig. 14-18). It is at this stage of the disease that rod in-
ner and outer segments begin to degenerate rapidly, and 
the number of outer nuclear layer nuclei decreases. The 
histogram illustrating disease severity with the number 
of phagocytic cells in the interphotoreceptor space indi-
cates a direct correlation between the two processes. Al-
most all the phagocytic cells that are present are re-
stricted to those areas having the more severe stage-2 
disease. In the late degenerative (stage-4) and atrophic 
(stages-5 and -6) phases of the disease, the number of 
phagocytic cells decrease (Aguirre, unpublished). This 
would suggest that the debris accumulating in the inter-
-
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FIGURE 14-19. The central (6._
0
) and peripheral (7._J retinal areas of 
a 3 year old prcd-affected dog with stage 3 disease. (6a) WGA strong-
ly labels the IPM space adjacent to the outer segments; there is diffuse 
but weak labeling of the remaining IPM. The surviving photorecep-
tors are well organized, except for the whorls of OS debris located on 
the RPE apical surface. WGA labels the RPE cone sheaths strongly (ar-
row). (6b) The PNA domain is thicker than normal, smooth and 
slightly "fluffy" in appearance. (6c) The composite shows the dimin-
ishing PNA label intensity at the RPE level (arrowhead). RPE lipofus-
photoreceptor space secondary to photoreceptor degen-
eration may serve as the signal for the invasion of 
macrophages. 
The interphotoreceptor matrix. Using the techniques of 
lectin cytochemistry, we have examined the molecular 
components of the insoluble IPM to determine if ab-
normalities are present in the prcd-affected retina, either 
before the development of the disease, or after the 
process of photoreceptor degeneration has been initiat-
ed (Mieziewska et al., 1993b; Mieziewska, 1993 ). Be-
cause of the topographic specificity for early degen-
eration in the inferior quadrant, we examined for 
differences between this quadrant and other retinal loci. 
We reasoned that degenerative changes in the visual cells 
could be initiated in response to a damaged matrix en-
vironment, irrespective of the nature of the primary de-
fect that is responsible for the cell dysfunction. Because 
the slow degeneration present in the prcd mutant retina 
allows diseased photoreceptors to remain viable for a 
cin granules were brightly labeled. The peripheral retina shows more 
advanced stage 3 disease. (7a) WGA label is strong immediately 
around the remaining cells (rods arrowhead, cones white arrow). 
(7b) PNA label is prominent and thick around cone IS and OS (ar-
row). Note that the cone matrix thickness differs when visualized with 
the WGA and PNA lectins (compare Figures 14-la and b, arrow). (7c) 
The composite shows the circumference and thickness of the PNA do-
main around rhe cones. Magnification X 1 ,000. (Reprinted from 
Mieziewska er al., 1993b.) 
relatively long period of time, the microenvironment of 
the IPM during degeneration may reflect more accu-
rately that present in RP, the comparable disease in man. 
With the exception of the late atrophic stages (stages 
5-8) of the disease, the lectin specificity remains normal 
in all the ages and stages examined. However, a thick-
ening of the rod and cone matrix domains is observed 
in some samples representing stages 2 and 3 (Fig. 14-
19). Since the change in thickness was observed at a rel-
atively advanced stage of degeneration, when substan-
tial cell death had already occurred, the thickening may 
represent a secondary response of the surviving cells. 
This response would maintain the structural integrity of 
the IPM and prevent the disruption of molecular flow 
through the IPM resulting from discontinuity in the 
structure. The number of photoreceptors remaining in 
the IPM compartment has been severely reduced by the 
time stage 2 is reached. The extra space is presumably 
occupied by broadened photoreceptors and matrix do-
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mains, as seen in later stages. Additionally, we found 
that the cone domains terminated somewhat more vir-
real to the RPE than normal, and, in the older affected 
animals with shorter PNA cone domains, WGA (wheat 
germ agglutin) strongly labeled the RPE cone sheath 
surrounding these cones. The significance of this find-
ing is unclear, but it could be the result of outer segment 
debris accumulation below the apical surface of the 
RPE. Extreme displacement of IPM material due to de-
bris accumulation has been shown in the RCS rats 
(La Vail et al., 1981; Porrello eta!., 1986). Our findings 
in the prcd mutant indicates that the photoreceptor-spe-
cific IPM constituents which form the insoluble IPM are 
not primarily involved in this hereditary retinal degen-
eration. 
Progressive Retinal Atrophy (PRA} in the Cat 
Similar hereditary retinal disorders have been recognized 
in other animal species. Brief mention will be made only 
of the diseases occurring in the cat, where both early-
and late-onset hereditary photoreceptor degenerations 
have been described. Three different early-onset disor-
ders have been identified; two are dominantly inherited 
(mixed-breed cats [West-Hyde and Buyukmihci, 1982] 
and Abyssinians [Barnett and Curtis, 1985; Curtis eta!., 
1987]), and one is recessively inherited in the Persian 
breed (Rubin and Lipton, 1973; Gaarder and Aguirre, 
unpublished). Surprisingly, all three diseases have a very 
early onset and rapid degeneration, and end-stage reti-
nal disease is evident on ophthalmoscopy by the time the 
animals are only a few months of age (Plates 14-V, 14-
VI). This is different from what is found in dogs with 
the comparable developmental photorecept~r diseases 
(Table 14-2). A late-onset, slowly progressive disease, 
also recognized in the Abyssinian breed, is inherited as 
autosomal recessive (Narfstrom, 1983). Both of the dis-
eases found in the Abyssinian breed are maintained in 
experimental colonies by different research groups, and 
confusion may arise in those not familiar with the pro-
found differences that exist between the two disorders. 
Heterozygous Abyssinian cats affected with the early 
onset rod-cone dysplasia (Rdy) show equal structural 
abnormalities in the rod and cone photoreceptors (Leon 
and Curtis, 1990). These remain rudimentary, and fail 
to form organized outer segments; in addition, there is 
delayed and incomplete photoreceptor synaptogenesis. 
Degeneration begins in the central retina and progress-
es to the periphery; by 30 weeks of age, two to five rows 
of nuclei remain in the outer nuclear layer. In the area 
centralis, the feline equivalent of the foveomacular re-
gion of primates, there is atrophy of the RPE and the 
choriocapillaris, and thinning of the overlying tapetal 
layer. These changes are presumably secondary, as they 
occur late in the disease process. Abnormalities in reti-
nal cyclic nucleotide metabolism have been reported in 
abstract form for the Rdy model (Leon et al., 1988 ), but 
not published. In that brief abstract, the authors re-
ported the presence of elevated retinal cGMP levels in 
affected animals in the earliest stages of the dystrophy, 
at a time when the cGMP-PDE activity was low. 
The late-onset, recessive degenerative photoreceptor 
disorder is characterized initially by disorientation of 
the rod disc membranes (Narfstrom and Nilsson, 1989). 
This is followed at approximately six months of age by 
disintegration of the rod outer segments, appearing as 
vacuolization and clumping of disc material and accu-
mulation of debris. Thereafter, rod cells are lost from the 
photoreceptor and outer nuclear layers. Cones develop 
and remain normal until two to three years of age, at 
which time degeneration begins (Narfstrom and Nils-
son, 1986). In several respects, this disease has many 
similarities to prcd in the dog, among which are the clin-
ical, cytological, and temporal characteristics of pho-
toreceptor degeneration, as well as the presence of 
abnormalities in plasma lipids, particularly docosa-
hexaenoic acid (22:6n-3; Anderson et al., 1991). 
Retinal pigment epithelial defects have not been de-
scribed in the Abyssinian cat with the late onset reces-
sive disease. Based on normal rhodopsin regeneration as 
determined in situ by imaging fundus reflectometry, the 
normal participation by the RPE in this aspect of the 
rhodopsin cycle is implied (Jacobson et al., 1989). Sim-
ilarly, normal RPE function has been established elec-
trophysiologically by measurements of the DC-record-
ed c-wave and direct measurements of the standing 
potential (Narfstrom et al., 1985). Normal dark-adapt-
ed sensitivity (Narfstrom eta!., 1988) and rhodopsin n!-
generation occur, even though a profound decrease in 
IRBP gene expression has been reported at both themes-
sage and protein levels (Narfstrom et a!., 1989a; Wig-
gert et a!., 1994). It is not clear how this finding relates 
to the retinal function, or its significance in terms of the 
identification of the molecular defect of the disease. To 
date, only the phosducin and peripherin!rds genes have 
been excluded from the disease (Gorin et a!., 1993, 
1995). 
THE RPE IN INHERITED DEFECTS 
Of LYSOSOMAL FUNCTION 
Our laboratories have been involved in studies of the 
RPE disease present in animals with lysosomal storage 
disorders. In both man and animals, these diseases are 
caused by the inherited deficiency of lysosomal en-
DISEASES OF THE RPE-PHOTORECEPTOR COMPLEX IN ANIMALS 279 
zymes, and represent generalized multisystemic abnor-
malities of which the ocular lesions are but one compo-
nent. That selective deficiency of an enzyme results in 
substrate accumulation indicates that the degradative 
pathway involved, as well as the substrate accumulat-
ing, are critical for the normal function of the tissue 
studied. These aspects of the diseases lend themselves to 
be used to define specific catabolic pathways essential 
for normal RPE function. Disease in the RPE is dra-
matic, and underscores the importance of the lysosomal 
system in the function of this cell layer. This is not sur-
prising, because compared with other tissues of the 
body the RPE shows a higher activity for most of the 
acid hydrolases and sulfatases (Hayasaka, 1974; Zim-
merman et al., 1983; Stramm et al., 1983; Aguirre and 
Stramm, 1991). Of this group of diseases, our focus has 
been primarily on those disorders involved in the degra-
dation of glycosaminoglycans (GAGs), known collec-
tively as the inherited mucopolysaccharidoses. 
Mucopolysaccharide (MPS} Storage Diseases 
Severe RPE pathology with no photoreceptor disease. We 
have examined the RPE in animals with mutations of 
three different lysosomal enzyme gene loci: arylsulfatase 
B (ASB; cat), a-L-iduronidase (a-L-id; cat) and 13-glucu-
ronidase (GUSB; dog) (see Table 14-4 and Aguirre and 
Stramm, 1991 for review). The lysosomal enzymes en-
coded by these genes participate in the degradation of 
GAGs. Morphologic studies of the three mutations in-
dicate that the accumulation of intracellular inclusions 
in secondary lysosomes serves as a distinct structural 
marker of the enzyme deficient RPE. By light mi-
croscopy, these inclusions appear vacuolated, or homo-
geneous and indistinct from the surrounding cytoplasm. 
Ultrastructurally, the inclusions can vary from electron 
lucent to granular, lamellar, or mixed (Fig. 14-20). The 
electron-lucent and granular vacuoles are believed to 
represent leached and stored GAGs, respectively, while 
lamellar inclusions result from lipid accumulation sec-
ondary to inhibition of ganglioside degradative path-
ways by the stored GAGs (Rushton and Dawson, 1977). 
Accumulation of secondary lysosomal inclusions in 
the enzyme-deficient RPE is the hallmark structural ab-
normality. Using the MPS-VI deficient mutant as the 
prototype disease, we have found that there is RPE hy-
pertrophy subsequent to the accumulation of vacuolat-
ed inclusions. In the RPE, single cytoplasmic inclusions 
are present initially in the early postnatal period. Their 
number and size increase during the period of photore-
ceptor differentiation. Subsequently, the RPE cells en-
large, and the monolayer becomes uniformly hypertro-
phied. In older animals, some of the enlarged cells 
become massively hypertrophied, and have a uniformly 
rounded apical border. These hypertrophied cells, which 
can have an apical-basal height greater than 25 mi-
crons, occur either singly or in clusters, and result in loss 
of the uniformity that is characteristic of the RPE mono-
layer (Fig. 14-21). Similar disease is present in the MPS 
VII RPE (Stramm et al., 1990). In contrast, the MPS-I 
affected RPE accumulates homogeneous inclusions that 
are not distinct from the surrounding cytoplasm, and 
RPE hypertrophy is minimal or absent (Stramm et al., 
1989). The inclusions represent stored GAGs that accu-
mulate in the diseased RPE cells (Fig. 14-22). 
In spite of the severe RPE pathology, there is complete 
preservation of neuroretinal structure and function. Ex-
amination of the ERG rod-and-cone system responses 
indicates maintenance of normal retinal function at a 
time when RPE storage is severe (Aguirre et al., 1986). 
Morphologic examination also shows that the internal 
lamellar organization of the rod outer segments is pre-
served, even though they appear disoriented when adja-
cent to massively hypertrophied RPE cells. In fact, out-
er segment lengths and renewal rate, an indication of the 
normal participation of the RPE in the outer segment re-
newal process, are normal when studied both early and 
late in the disease (Fig. 14-23). It is apparent, therefore, 
TABLE 14-4. diseases in animal models 
Number Animal 
MPS I* Hurler Cat, dog a-L-Iduronidase 
MPS II Hunter Dog Iduronate-2-sulfatase 
MPS IIID Sanfilippo Goat N-Acetylglucosamine 
6-Sulfatase 
MPSVI* Maroteaux-Lamy Cat, dog, rat Arylsulfatase B 
MPS VII* 
DS = dermatan sulfate HS heparan sulfate CS = chondroitin sulfate 
*Extensive RPE storage of substrate has been reported; refer to text for details. 
Stored GAGs 
DS,HS 
HS,DS 
HS 
DS 
DS,HS, CS 
280 INHERITED AND METABOLIC DISORDERS 
FIGURE 14-20. Nonpigmented RPE cell from the tapetal zone (arrow) 
of an MPS VI-affected cat (ASB deficiency) accumulates electron lu-
cent (1), granular (2), lamellar (3), and mixed (4) inclusions in sec-
ondary lysosomes. The inclusions are membrane limited and distinct 
from mitochondria (M). N nucleus. Magnifications: (A) X5,700; 
(B) X 19,000; (C) X 17,500. (Reprinted from Aguirre et al., 198.3.) 
that the diseased RPE cells, in spite of their massive hy-
pertrophy, are still able to maintain their photoreceptor-
supportive functions. Similar preservation of photore-
ceptors occurs in both the MPS I (cat) and VII (dog) 
models, although, .in the latter, there is disorientation of 
cone outer segment disc membranes (Aguirre et al., 
1986; Aguirre and Stramm, 1991). Of all the MPS mod-
els reported, photoreceptor degeneration occurs only in 
the MPS VII mouse (Lazarus et al., 1993). 
The interphotoreceptor matrix in MPS VII. [j-glucuro-
nidase, the enzyme deficient in MPS VII, is involved in 
the degradation of the three principal GAGs present in 
the RPE: chondroitin sulfate (CS), dermatan sulfate 
(DS), and heparan sulfate (HS). Of these, heparan and 
chondroitin sulfates have important biological activities 
in, respectively, mediating cell-to-cell interaction and be-
ing an important molecular constituent of the main class 
of proteoglycans present in the IPM (Stramm et al., 
1989; 1990). Of the cells bordering the interphotore-
ceptor space, it is only the RPE that is involved in the 
degradation of the CS component of IPM proteoglycans 
(Stramm et al., 1990). Because of the severe disease that 
occurs in the RPE from GUSB deficiency, it is plausible 
that an equally severe abnormality would occur in the 
IPM. For that reason, we have examined the matrix in 
normal and mutant animals using a series of antibodies 
and lectins directed at different molecular constituents of 
this structure. Surprisingly, we have found only a minor 
alteration in the matrix (Long et al., 1989; Long and 
Aguirre, unpublished). The distribution of chondroitin 
sulfate proteoglycan species (0-S, 4-S, and 6-S) is normal, 
although there is a condensation of the 6-S molecular 
species limited to the area of the cone matrix sheath. 
Within this sheath, some of the cone outer segments 
show a nonprogressive disorientation of the "coin-
stack" organization of the discs. However, the major 
portion of the matrix and the rod photoreceptors are 
normal (Fig. 14-24 ). In contrast, the elegant studies of 
the MPS VII mouse retina by Lazarus and colleagues 
have shown that abnormalities of the IPM occur early, 
and that changes in its biochemical composition or phys-
ical structure may be causally associated with the subse-
quent photoreceptor degeneration (Lazarus et al., 1993 ). 
The topography of RPE disease is not uniform. The lyso-
somal enzymes serve general "housekeeping" functions 
in the catabolism of complex macromolecules that are 
targeted to the lysosomal compartment during the re-
modeling and turnover of cell membranes and extracel-
lular matrices. Because of their ubiquitous distribution 
in all tissues, including the RPE, and the presumably 
uniform function of this cell layer in the eye, one would 
expect that enzyme deficiency would .result in uniform 
disease expression within the monolayer. However, this 
is far from the case. 
In the MPS VI-deficient mutant, the number of RPE 
inclusions increases with time, but this increase cannot 
be considered strictly age dependent, as it is strongly 
modified by topographic factors which appear to regu-
late disease expression. A striking feature of the ASB-de-
ficient RPE is the lack of uniformity in the expression of 
the disease phenotype. This is clearly demonstrated in 
Figure 14-25, which compares disease in nonpigmented 
(A) and pigmented (B) RPE cells from equivalent posi-
tions in the superior and inferior quadrants of the same 
adult eye; the nonpigmented RPE becomes massively 
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FIGURE 14-21. Nonpigmented RPE from the tapetal zone of MPS 
VI-affected cats of different ages. (A) 6 months; (B) 9.5 months; 
(C)-(F) 5 years. (A) vacuolated inclusions fill the cytoplasm without 
causmg hypertrophy. (B) the height of the RPE cells increases concur-
rent with the accumulation of larger vacuoles. (C)-(F) Hypertrophy 
of the RPE cells, either singly or in clusters, results in focal disarray of 
hypertrophied while the pigmented RPE remains nor-
mal. In general, two spatial gradients are present in the 
ASB-deficient RPE (Aguirre et al., 1983). These are (a) 
central-to-peripheral gradient within the same quad-
rant: The RPE disease always is more severe in the pos-
terior pole than in the periphery although, with aging, 
disease in the periphery increases in severity; and (b) 
quadrant- (pigmentation-) specific distribution: The RPE 
abnormality is not distributed equally about the optic 
disc, but has the same disposition as that of nonpig-
mented RPE cells in the superior, temporal, and nasal 
meridians. That is, areas of the RPE monolayer that are 
nonpigmented and over the tapetum lucidum show 
marked RPE storage, while minimal-to-no storage is 
the outer segment layer. Note that photoreceptor disorientation is not 
accompanied by disease. Arrowheads (A) indicate a necrotic celt that 
is not associated with the ASB deficiency; asterisks (C) denote normal 
choriocapi!laris indentation of the basal RPE. Magnifications: (A), 
(B), (E), (F) X830; (C), (D) X650. (Reprinted from Aguirre et a!., 
1983.) 
present in areas where the RPE is pigmented (Fig. 14-
26; compare with Fig. 14-3). In older animals, the rela-
tionship between RPE pigmentation and absence of dis-
ease decreases in all quadrants, as progressively more 
pigmented cells accumulate secondary lysosomes and 
become hypertrophied. The disease phenotype, howev-
er, is always less severe in the pigmented RPE. 
The lack of uniformity in the response of the RPE to 
an inherited lysosomal enzyme deficiency raises ques-
tions concerning topographic variability in the function 
and metabolism of the cell layer. It is possible that 
RPE ASB enzyme activity normally is not the same 
throughout the monolayer and, in the affected RPE 
cells, substrate accumulates m those regions having a 
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FIGURE 14-22. Scanning densitometry tracing of Alcian Blue-stained 
GAGs separated by cellulose acetate electrophoresis from freshly 
isolated RPE cells of a normal cat, and cats affected with MPS I (a-L-
id-) and MPS VI (ASB-). The tracing of the normal RPE cell GAGs 
shows three distinct peaks, the faster migrating doublet of chondroitin 
more profound deficiency. This is not an unreasonable 
hypothesis, as the activities of several lysosomal en-
zymes have been shown to exhibit regional variations 
(Burke and Twining, 1988; Cabral et al., 1990). Other 
mechanisms that explain the milder disease. phenotype 
of pigmented RPE may be the presence of alternate 
degradative pathways, a protective action by pigment, 
or regional differences in GAG metabolism (synthesis, 
secretion, and/or internalization). Recent in vitro stud-
ies, discussed below, indicate that regional differences in 
GAG metabolism determine the disease topography, 
and that these differences are not the result of the pres-
ence of the tapetum lucidum, but are dependent on the 
positional origin of the RPE cells. 
A lack of spatial uniformity in RPE disease expression 
is also present in the MPS I feline model. However, be-
cause the disease phenotype is not as dramatic as in MPS 
VI (inclusions are homogeneous rather than vacuolated, 
and RPE cell hypertrophy is absent), it has been more 
difficult to ascertain the disease topography. As in the 
MPS VI model, we have found that accumulations of 
secondary lysosomes in the a-L-iduronidase-deficient 
sulfate/derma tan sulfate, and the slower isolated heparan sulfate peak. 
In both diseases there is an accumulation of GAGs, particularly der-
matan sulfate. (Reprinted with modification from Aguirre and 
Stramrn, 1991.) 
RPE occur primarily in the superior quadrant where the 
RPE is not pigmented. In this area, the inclusions occu-
py approximately 18% ofthe cytoplasmic space. In con-
trast, RPE cells from the inferior quadrant accumulate 
a much smaller number of inclusions, and these occupy 
no more than 5%-6% of the cytoplasmic area. With the 
exception of melanin, which is not present in the supe-
rior (central and equatorial) quadrant, there are no dif-
ferences in the presence and distribution of other cellu-
lar organelles (Stramm et al., 1989). 
In vitro expression of RPE disease. Biochemical studies 
on the RPE are difficult to perform; only small quanti-
ties of tissue can be obtained from a single eyecup, and 
the material is often contaminated by other cell types. 
In vitro studies overcome these limitations by allowing 
the preparation and amplification of pure populations 
of RPE cells. The use of a controlled tissue culture envi-
ronment allows for the precise determination of the role 
of metabolic/degradative pathways in normal RPE func-
tion. The in vitro systems also are amenable to studies 
of the regulation of selected pathways, both at the eel-
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FIGURE 14-23. The RPE in feline MPS VI. Focal disorientation of out-
er segments opposite a massively hypertrophied RPE cell (lower inset). 
The internal lamellar organization of the outer segments is normal 
(main figure}, but the RPE cytoplasm is full of vacuolated inclusions, 
and few organelles are recognizable (M = mitochondrion). Three days 
after the intravitreal injection of 3H-leucine {upper inset), a band of 
lular and molecular level, and are useful for developing 
methodologies for correction of the metabolic defects at 
the gene level. Other chapters in this book discuss the 
use of tissue culture to study RPE function and metab-
olism. In this section, we address the use of in vitro 
methods in the study of inherited lysosomal deficiencies 
in the RPE; this topic has been reviewed previously 
(Aguirre and Stramm, 1991). Of the four lysosomal 
storage diseases studied in our laboratories (MPS I [dog 
and cat], VI [cat] and VII [dog]; a-mannosidase defi-
ciency [cat]), all show in vitro retention of the morpho-
logic, biochemical and molecular characteristics of the 
disease (Aguirre et al., 1995; Ray et al., 1996; Ray et al., 
1997; Stramm et al., 1985, 1986, 1989, 1990). Studies 
presented in this section focus on the disease present in 
the MPS VI cat model. 
silver grains is present in the autoradiogram midway along the outer 
segment length in rods located opposite hypertrophied and diseased 
RPE cells. This indicates that renewal is normal in spite of severe RPE 
disease. Arrow in main figure indicates apical microvilli of the RPE. 
Magnification: X10,000 for main figure; insets X850. (Reprinted 
from Aguirre et al., 1986.) 
MPS VI in vitro disease. Primary cultures of RPE cells 
initiated from the entire eyecup of cats with MPS VI 
show that there is a profound decrease of ASB activity, 
typically 5%-10% of normal (Stramm et al., 1985). 
This low level, termed residual enzyme activity, is insuf-
ficient to prevent the morphological manifestations of 
the disease, and the MPS VI-affected cells accumulate 
intracellular inclusions identical to those found in situ 
(Fig. 14-27). In RPE cultures from heterozygotes, the ac-
tivity of ASB is reduced to approximately 50% of nor-
mal. Since these cells are phenotypically normal, both in 
vitro and in vivo, it appears that this level of enzyme ac-
tivity is sufficient to prevent expression of the disease. 
One can conclude, therefore, that ASB activity must be 
reduced below some critical level in the MPS VI RPE be-
fore disease is expressed morphologically. One also may 
284 INHERITED AND METABOLIC DISORDERS 
CHONDROITIN SULFATE 6-S 
NORMAL 
FIGURE 14-24. Schematic illustration of IPM layer immunocyto-
chemical labeling with antibody directed against the 6-0 species of 
chondroitin sulfate proteoglycan in normal and MPS VII-affected dog 
retinal sections. In both there is diffuse and similar labeling through-
out the !PM. In the MPS VII retina, however, there is a condensation 
infer from these observations that it may not be neces-
sary to restore 100% of the deficient enzyme activity to 
restore normal function to the diseased cells. 
In a previous section, we showed that the topography 
of the RPE disease in MPS VI was not uniform, and that 
cells in the posterior pole exhibited massive intracellu-
lar storage while those in the far periphery showed lit-
tle or no accumulation of undegraded substrate. With-
in the posterior pole, however, storage of undegraded 
substrate was more severe in the superior than in the in-
ferior regions. To examine the factors that contribute to 
the region-specific distribution of RPE disease, we have 
studied the in vitro RPE isolated from regionally defined 
areas of the monolayer. In contrast to the isolation 
method that harvests cells from the entire eyecup 
(Stramm et al., 1983), regional cultures isolate cells 
from topographically preselected regions by using small 
glass cylinders or cloning rings to demarcate the sam-
MPS VII 
also of immunoreactivity in the matrix around the cone inner and out-
er segments, and intense labeling of the inclusions present in the RPE. 
Note the disorientation of the cone outer segment discs, and the ex-
tension of a long calyceal process. (Long and Aguirre, unpublished.) 
pled area (Stramm et al., 1985; see Aguirre and Stramm, 
1991 for review). A limitation of the method is that only 
a small sample of cells can be harvested, but, when seed-
ed at a high density, they are highly differentiated and 
remain pigmented if isolated from the nontapetal re-
gions of the eye. 
MPS VI-topographic preservation of disease in vitro. 
Regional cultures have been initiated from cells isolated 
from the superior and inferior regions of the eye. We 
have found that the accumulation of inclusions, repre-
senting stored substrate in secondary lysosomes, occurs 
primarily in cultures initiated from the posterior pole 
and superior equatorial regions, and not in those initi-
ated from the inferior regions or periphery (Fig. 14-28). 
This region-specific in vitro disease phenotype is identi-
cal to what is observed in situ, and reflects differences 
in substrate accumulation that are topographically de-
termined. However, disease is not the result of regional 
-
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FIGURE 14-25. Sections from the tapetal (A-pigment epithelium not 
pigmented) and nontaperal (B-pigment epithelium pigmented) zones 
of a cat with .'v1PS VI. As a result of arylsulfatase B deficiency, the non-
pigmented RPE becomes massively hypertrophied (A) and accumu-
lates cytoplasmic vacuolated inclusions. The pigmented Rl'E remains 
normal (B). Magnification X420. (Reprinted from Aguirre et al., 
1986.) 
differences in expression of the deficient (ASB) enzyme. 
For example, cell cultures initiated from the inferior and 
peripheral regions of the eye, which show no substrate 
storage, have equally deficient ASB activity as cultures 
from the superior regions and posterior pole, areas 
which exhibit massive substrate accumulation. This is 
similar to what occurs in normals, where ASB activity is 
uniform, but high, throughout the monolayer (Stramm 
et al., 1986). 
Regional differences in RPE metabolism of GAGs deter-
mine disease topography. To determine the factors that 
regulate the topography of disease expression in MPS 
VI, we have examined the regional metabolism of GAGs 
in the RPE using an in vitro approach. The extent of ra-
diolabeled GAG accumulation was dependent on the 
topographic origin of the cells. The accumulation of 
GAGs within the cell layer was much greater in cultures 
initiated from the superior region of the eye than in cul-
tures from the inferior region (Fig. 14-29). This is in 
agreement with our in vivo and in vitro morphologic re-
sults {Aguirre et al., 1983; Stramm et al., 1986). In con-
trast to the cell layer, the media from affected cultures 
initiated from the inferior region of the eye contained 
much higher levels of DS/CS than cultures from the su-
perior region, and this difference in the release of new-
ly synthesized GAGs into the media between regions 
was sustained during the 72-hour chase period. Associ-
ated with the accumulation of GAGs, there was a sig-
nificant increase of collagen production in nonpigment-
ed cultures from the superior quadrant (Stramm et al., 
1991}. 
Our studies show that the region-specific alterations 
in both cell layer storage of GAGs and the release of 
GAGs into the media are maintained in vitro in the pres-
ence of a lysosomal enzyme deficiency that uniformly 
affects both regions of the RPE. This finding indicates 
that additional pathways for GAG turnover exist in the 
RPE, and are more active in the less severely diseased re-
gions. The alternate pathways do not appear to operate 
in a regionally selective manner in normal RPE, as evi-
denced by similar GAG synthesis and secretion profiles 
in cultures initiated from different areas of the eye. In 
the disease, however, the function of these pathways ap-
pears to be selectively increased in cells derived from 
specific regions of the eye. Such regionally selective 
processes indicate that the RPE, although a monolayer, 
must not be considered to be homogeneous in its func-
tion and metabolism. This is of critical importance for 
the studies of RPE diseases which are expressed in a 
topographically specified site, such as AMD. 
a -Mannosidosis 
Our studies of the RPE in the mucopolysaccharidoses 
have illustrated the importance of the lysosomal-
degradative pathways for the turnover of GAGs locat-
ed in the RPE cell coat, or in the extracellular matrices 
that surround this cell layer {see Aguirre and Stramm, 
1991 for review). Our results emphasize also that RPE 
disease per se is not causally associated with visual cell 
disease and neuroretinal degeneration. It could be ar· 
gued that lysosomal degradation of RPE GAGs, al-
though important for the turnover and remodeling of 
cell surface and matrix proteoglycans, is not sufficient 
by itself to cause visual cell disease when a degradative 
pathway is impaired by an inherited disease. However, 
similar preservation of photoreceptor integrity is main-
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FIGURE 14-26. Schematic representation of the distribution of PEdis-
ease, pigmentation and the of the tapetum lucidurr. in the eye 
of a young MPS cat. For comparison with the normal see 
Figure 14-3. The eye is drawn to scale based on observati.ons of se-
quential 150 f.Lm fields from the disc to the ora serrata 
{curved line). Note that the tapetum is present pri~arily in the supe-
rior, nasal, and temporal meridians. The pigment epithelium is not 
pigmented in areas where the tapetum is present. Disease in the pig-
ment epithelium, characterized by the accumulation of vacuolated in-
tained in another lysosomal-storage disorder which is 
critically involved in rhodopsin degradation. 
Acidic a.-mannosidase is one of several lysosomal ex-
oglycosidases which sequentially remove sugars from 
the nonreducing ends of glycoproteins (see Aguirre et 
al., 1986 for review of animal models of mannosidosis 
and fucosidosis). Since rhodopsin is the predominant 
mannose-containing glycoprotein presented to the RPE 
for degradation, enzyme deficiency results in the pro-
gressive accumulation of complex N-linked mannose 
pentasaccharides (DeGasperi et al., 1991; Alroy et al., 
1991). The RPE disease in this mutant is far more severe 
Right eye 
MPS VI affected 
16 montha of agel 
elusions and cellular hypertrophy, is more severe in areas where the 
cell layer is not pigmented. This is most dramatic in the superior 
meridian. Key: arrows indicate the presence of tapetum; RPE pig-
mentation varies from absent (empty) to moderate (density present in 
the far periphery); RPE disease varies from normal (empty) to mod-
erate (darker shading indicates that >50% of the cell volume is occu-
pied by vacuolated inclusions and hypertrophy is present). (For details 
refer to Aguirre et al., 1983, from which this figure was reprinted.) 
and far more rapidly progressive than in the compara-
ble mutants with defects in GAG degradation. The cy-
toplasm is full of secondary lysosomal inclusions, and, 
other than compacted and often distorted nuclei, it is 
difficult to identify cellular organelles (Fig. 14-30). In all 
other respects, however, the RPE appears to function 
normally. The participation of the RPE in the outer seg-
ment renewal process is evident by the accumulation of 
phagosomes in the apical cytoplasm, even though the 
degradation of rhodopsin containing outer segment ma-
terial is incomplete (Aguirre, Haskins, and Ray, unpub-
lished; Aguirre et al., 1995). The outer segments are 
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FIGURE 14-27. MPS VI-affected cat RPE after 14 days in tissue cul-
ture retains a differentiated phenotype as well as the essential features 
of the disease (compare wirh Figure 14-20). There is accumulation of 
storage in secondary lysosomes; the inclusions appear electron lucent 
structurally normal, but their average length is reduced 
by approximately 40%-SO'Yo. Similar changes in the 
RPE have been described in cattle with hereditary a-
mannosidase deficiency (Jolly et al., 1987)_ 
The a.-mannosidase-deficient mutant has a short life-
span, and most animals die in their first year. It is likely 
that such a severe deficiency, if sustained for years in an 
animal or for decades in a human, would eventually re-
sult in photoreceptor degeneration secondary to RPE 
disease. What is more difficult to evaluate, however, is 
the effect of a severe but long-term change in the ac-
tivity of a.-mannosidase or another RPE lysosomal en-
zyme as the result of aging (Wyszynski et al., 1989; 
Boulton et al., 1994). While there may be an effect on 
the RPE and neuroretina, our studies in the mutant an-
imals would suggest that the effect is likely to be com-
plex, and modified by other factors, both genetic and 
environmental, which play a role in the aging eye. Such 
issues are particularly relevant to a complex disorder 
such as AMD in man, and continuing studies of the RPE 
system in these animal models are crucial to clearly 
(1), granular (2), lamellar (3), or mixed (4). N nucleus, M = mito-
chondria, circle = apicolateral junctions, arrowhead culture plate. 
Magnification X9,400. (Reprinted from Stramm et al., 1985.) 
defining the importance of the lysosomal degradative 
pathways in the metabolic pathways of this cell layer. 
Experimental Therapy of the RPE 
in Lysosomal Storage Disorders 
Following the in vitro demonstration that soluble "cor-
rective factors" are released into the media and reverse 
substrate storage in diseased cells (Fratantoni et al., 
1968), various strategies have been used to treat the 
lysosomal storage disorders. Therapy has been directed 
toward restoring the deficient enzyme function by en-
hancing residual activity (Vine et al., 1982), by provid-
ing normal enzyme directly, or, indirectly, by trans-
planting bone marrow or other cells (Krivit et al., 1984; 
Summers et al., 1989; Wenger et al., 1986; Haskins et al., 
1991; Akle et al., 1985). More recently, gene therapy us-
ing in vivo or ex vivo correction has been accomplished 
experimentally and in clinical trials. Because the disease 
may be variable within and between the different clini-
cal entities, and most patients show the disease pheno-
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FIGURE 14-28. MPS VI-affected cat RPE cells after 14 days in pri-
mary culture. The cells were isolated from defined regions of the eye. 
The top three sections are of cultures initiated from the superior equa-
torial region; the three lower sections are from the inferior equatorial 
region. Although the cultures have equal and deficient levels of ASB 
activity, only the cells isolated from the superior region are diseased. 
Magnification X800. (Reprinted from Aguirre and Stramm, 1991.) 
type at the time therapy is initiated, it has been difficult 
to establish criteria by which the success of therapy can 
be evaluated. Determination of enzyme activity in the 
serum or leukocytes provides an objective measure-
ment, but one that may not be appropriate, as the as-
says generally are made using artificial rather than nat-
ural substrates. Consequently, the presence of normal 
activity in the blood does not necessarily mean that nor-
mal degradative function is occurring in the lysosomal 
compartment of the other affected tissues. In collabora-
tion with associates (M. Haskins and J. Wolfe) at the 
University of Pennsylvania, our laboratories have ex-
amined the effect of bone marrow transplantation 
(BMT) on the RPE disease phenotype, and have begun 
experimental gene therapy studies. These areas are dis-
cussed below. 
Correction of RPE disease phenotype following bone mar-
row transplantation. Our laboratories have examined 
the RPE in animal models of MPS VI (cat), VII (dog), 
and a-mannosidosis (cat) following successful BMT (see 
Haskins et a!., 1991 for review). Within each disease, 
the results were consistent, but demonstrated that the 
response to BMT was disease specific. This response ap-
pears to be dependent on the amount of enzyme that is 
A 
B 
Cell uyw Dermetan/Chondroltln Sulf8te 
6000 
4000 
Media Dermatan/Chondroltln Sulfate 
FIGURE 14-29. Cell layer (A) and media (B) GAGs (dermatan sul-
fate/chondroitin sulfate; DS/CS) at the end of a 72-hour period of la-
beling with 35S04 . Accumulation of radio-labeled DSICS in the RPE 
is significantly elevated in MPS VI-affected (ASB·) cultures initiated 
from the superior region of the eye (P < 0.02). No regional differences 
are present in the normal (ASB+) RPE. Release to the media of radio-
labeled DSICS at the end of a 72-hour labeling period is significantly 
elevated in MPS VI-affected {ASB·) cultures initiated from the inferi-
or region of the eye (P < 0.0005). Although not as dramatic, release 
of 35S-DSICS also was significantly elevated in affected cultures initi-
ated from the superior region of the eye (P < 0.01). No regional dif-
ferences were present in the normal (ASB+) cultures. Mean ±SEM. 
Cultures from superior (nonpigmented) region open bars; cultures 
from inferior (pigmented) regions dark bars. (Reprinted from 
Stramm et al., 1991.) 
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FIGURE 14-30. RPE disease is severe in a young cat affected with c:x· 
mannosidase deficiency. The RPE cells are hypertrophied, and the cy-
toplasm is full of vacuolated inclusions representing incompletely di-
gested substrate that has been leached during tissue processing. The 
RPE nucleus is indented (arrow) by the inclusions that surrounded it; 
phagosomes (arrowhead) are prominently located in the RPE apical 
region. Although the rod outer segments are shortened, the photore-
ceptors are intact, but they accumulate inclusions in the inner segment 
and perinuclear region. Magnification X1,250. (Aguirre, Haskins and 
Ray, unpublished.) 
normally present extracellularly, and released by the 
transplanted cells. 
Even though MPS VI-affected animals have shown 
improvement in some tissues after BMT (Gasper et al., 
1984), we have not observed any modification of the 
RPE disease phenotype (Aguirre, Haskins, and Thrall, 
unpublished). In these animals, the RPE cells continue 
to hypertrophy as they progressively accumulate cyto-
plasmic vacuolated inclusions. A similar lack of correc-
tion has been found in the cornea, either following BMT 
(Aguirre, unpublished) or after reciprocal corneal trans·· 
plantation where MPS VI-affected corneal buttons were 
transplanted to corneas of genetically normal animals 
(Aguirre et al., 1992). In order to correct the disease in 
the RPE and other tissues following BMT, the normal 
enzyme has to be released from the hematopoietically 
derived donor cells and has to enter the target cells by a 
receptor-mediated internalization process with subse-
quent targeting to the lysosomal compartment. There, 
the active enzyme is able to degrade stored substrate and 
prevent the subsequent GAG accumulation in the sec--
ondary lysosomes. Lack of correction of the RPE disease 
could result from one or a combination of different 
mechanisms: low levels of enzyme in the extracellular 
compartments, failure of diffusion of enzyme from the 
vascular compartment to the RPE, or failure of the af-
fected RPE cells to internalize the secreted extracellular 
enzyme. Based on in vitro studies of the RPE, it appears 
that lack of correction results from the extremely low 
availability of ASB in the extracellular compartment. 
Unlike other lysosomal enzymes, ASB activity is pri-
marily intracellular, with very little release to the extra-
cellular compartment (Ray, unpublished). 
In contrast, MPS VII-affected dogs show moderate 
correction of the RPE disease phenotype after long-term 
BMT. Many areas of the RPE monolayer show absence 
of storage, while others show small clusters of cells with 
cytoplasmic vacuolated inclusions (Fig. 14-31, B). Over-
all, there is no cellular hypertrophy, and BMT results in 
marked improvement of the RPE disease (Aguirre, Ray, 
and Haskins, unpublished). Associated with the BMT, 
there is a dramatic clearing of the cornea, and general-
ized improvement of the multiorgan disease that is nor-
mally present in canine MPS VII (Haskins eta!., 1992). 
Similar studies have been carried out in the mouse mod-
el of MPS VII. Dramatic improvement of the disease phe-
notype was observed in all tissues except the RPE and 
retina, presumably because the high doses of irradiation 
given in the perinatal period prior to BMT resulted in 
complete retinal degeneration (Sands eta!., 1993). 
We have found that the most remarkable correction of 
RPE storage occurs following BMT in the feline model 
of a-mannosidosis. Eighteen months after transplanta-
tion, the RPE disease is completely reversed-the cyto-
plasmic inclusions disappear, cell size returns to normal, 
and cellular contours are restored (Fig. 14-31, A). As a 
result of the correction of the RPE disease, the photore-
ceptor outer segments resume normal orientation and 
elongate (Aguirre and Haskins, unpublished). As in the 
MPS VII-treated animals, there is correction of the stor-
age in other organs, particularly the CNS, and the severe, 
progressive neurologic disease is prevented (Haskins, un-
published; Walkley eta!., 1994). The success of correc-
tion of the RPE disease phenotype in both models prob-
ably results in part from the high levels of extracellular 
enzyme present following BMT. We have found that the 
RPE in culture has a very high level of cellular GUSB and 
a-mannosidase activity, and that it releases into the me-
dia catalytically active protein (Ray et al., 1997; Ray, un-
published). It is this extracellular enzyme that presum-
ably is involved in the correction of disease in distant 
target tissues. These studies demonstrate that RPE dis-
ease can be treated by the systemic route as long as the 
corrective factor being supplied to the diseased cells is 
available in the extracellular environment. 
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A 
B 
FIGURE 14-31. Improvement of RPE disease following long term 
bone marrow transplantation in a cat with o:-mannosidosis (A), and 
a dog with MPS VII (B); the transplantation intervals are 2 years and 
18 months, respectively. In o:-mannosidosis (A), the RPE is normal and 
the photoreceptors have elongated and are now of normal length 
(compare with Figure 14-30). In contrast, the treated MPS VII dog still 
shows some accumulation of vacuolated inclusions in the RPE, but no 
hypertrophy. At this stage the RPE would show marked hypertrophy 
and the cytoplasm would be full of vacuolated inclusions. Magnifica- · 
tion X800. (Aguirre and Haskins, unpublished.) 
Gene therapy of RPE disease in lysosomal storage disor-
ders. The prospects of genetically altering cells and/or 
organisms that have inherited defects have been im-
proved by the recent advances in molecular biology. In 
order to genetically engineer the cells, the foreign DNA 
sequence or gene must not only be introduced into the 
cell, but also needs to be expressed. Microinjection, 
electroporation, and calcium phosphate (or dextran sul-
fate) coprecipitation of DNA have been the traditional 
methods by which foreign DNA has been transferred 
into cells. However, each of these methods has inherent 
limitations. In some cases, a large number of cells need 
to be injected; in others, the efficiency of transfection 
and/or expression is low. 
The use of retroviral vectors to mediate gene transfer 
has overcome many of the limitations inherent in other 
methods of DNA transfer. By altering the structure of 
internal retroviral sequences, these vectors lack the 
polymerase and glycoprotein genes essential for replica-
tion, and contain instead the foreign DNA that is to be 
transferred. The deleted sequences, or trans acting func-
tions, are provided by a packaging cell line which de-
termines the host range and viral titers produced (Miller 
and Buttimore, 1986). These retroviral vectors are in-
fective but replication incompetent, and they usually re-
sult in the high-efficiency transfer of the foreign DNA. 
Their disadvantage, however, is that the transferred 
DNA integrates randomly into the host cell chromo-
somes. 
For most of our studies we have used retroviral vec-
tors which have internal promoters and the eDNA se-
quences to be transferred (Armentano et al., 1987; 
Wolfe et al., 1990) (Fig. 14-32) These vectors are de-
signed to use two different promoters (the strong pro-
moter from the retroviral5' long-terminal repeat [LTR] 
and an independent internal promoter) to regulate the 
expression of two different genes: the neo gene and the 
transferred eDNA. The neo gene confers resistance to 
the neomycin analog G-418, and provides a means for 
selecting in vitro those cells infected and transduced by 
the retroviral vector; that is, only transduced cells will 
survive when G-418 is added to the culture media. We 
also have used other vectors without internal promoters 
or selectable marker genes, and have found them to be 
LTRt------{~N~EQO~ 
NTK-BGEO 
LTRt--------------1JPBG~K[}=:JhA~S~B~cDQB~6A==~ 
PGK-hASB 
FIGURE 14-32. Retroviral vectors used to mediate eDNA transfer to 
the RPE. The NTK-BGO vector contains the rat [3-glucuronidase 
eDNA driven by the herpes simplex thymidine kinase (TK) promoter, 
and the neo gene is used for selection of the transduced cells. A simi-
lar vector contains the SV-40 promoter to regulate the rat GUSB 
eDNA expression (see Wolfe et al., 1990, for details). The PGK-hASB 
vector has the human arylsulfatase B eDNA under the control of the 
mouse phosphoglucokinase-1 (PGK) promoter, but no selectable 
marker. (LTR) = long terminal repeat. (Ray et al., 1995.) 
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equally effective in transferring and expressing a foreign 
DNA in cultured RPE cells (Fig. 14-32). 
In vitro correction RPE disease in MPS VII (dog} and 
MPS Vl(cat}. The rat GUSB eDNA has been transferred 
in vitro to the RPE of MPS VII-affected dogs using one 
of two different N2-derived retroviral vectors that con-
tain the entire coding sequence of the rat GUSB eDNA 
(Nishimura eta!., 1986; Wolfe et al., 1990). The differ-
ence between the vectors is in the internal promoter used 
to drive the heterologous eDNA; these are the simian 
virus 40 (SV-40) and the herpes simplex thymidine ki-
nase (TK) promoters, which are cloned upstream from 
the rat GUSB eDNA (Fig. 14-32). Both the SV-40 and 
TK promoters are constitutive promoters with no RPE 
specificity, yet the level of expression of the gene they 
regulate is sufficient to correct the inherited RPE defect 
(see below). It appears, therefore, that nonspecific pro-
moters can be used in the RPE to regulate the expres-
sion of a gene that subserves a critical degradative func-
tion. Use of these vectors in high concentration (2 X 106 
CFU/ml) results in high efficiency of RPE cell transduc-
tion without any impairment of cellular growth, me-
tabolism, or viability (Stramm et al., 1990; Wolfe et al., 
1990; Ray et al., 1992). 
Following retroviral mediated GUSB eDNA transfer, 
the MPS VII-affected RPE cells show complete restora-
tion of GUSB activity. This represents approximately a 
three- to five-hundred-fold increase in activity from the 
levels measured in untreated affected cells. The effect is 
specific, as the activity of other lysosomal enzymes re-
mains normal and unchanged (Table 14-5; Ray, unpub-
lished). These results have been confirmed in separate 
experiments using RPE cells from different affected dogs 
and the same vector constructs. We have found that the 
GUSB activity present in the vector-treated RPE cells is 
catalytically active on the natural substrate, and corrects 
the block in GAG degradation. Following 72 hours of 
continuous labeling with 35S04 , the synthesized GAGs 
retained by the cell layer of the vector-treated cells are 
the same as in normaL In contrast, the untreated, af-
fected cells accumulate heparan and chondroitin sul-
fates (Figs. 14-33, 14-34 ). The restoration of normal 
GAG-degradative function in the vector-treated cells oc-
curs specifically in the cell layer compartment, as there 
are no changes in the media GAGs to indicate increased 
secretion or enhanced extracellular degradation. The lo-
calization of GUSB activity in the lysosomal compart-
ment of the MPS VII vector-treated cells has been 
demonstrated histochemically (Wolfe et aL, 1990). 
Similar studies have been carried out in MPS VI cat 
RPE cells having a deficiency of ASB (Ray et al., 1995). 
Transduction of RPE cells was done using a retroviral 
vector containing the human ASB eDNA driven by the 
TABLE 14-5. Lysosomal enzyme activities in cultured 
MPS and vector-treated RPE cells 
Experiment # 1 
MPS VII 
Experiment # 2 
MPS VII 
MPS VIUTK1 
Experiment # 3 
MPS VII 
MPS VIUTKl 
MPS VIIISV8 
5%* 
0.3%* 
117% 
0.2%* 
71% 
102% 
a-L-iduronidase 
(a-mannosidase) 
(88%) 
107% 
103% 
88% 
84% 
118% 
Table reproduced from Aguirre and Stramm, 1991 and contains 
data from Wolfe et al., 1990 and Stramm et al., 1990. 
Enzyme activities determined as nmol of substrate cleaved/hour/mg 
protein and expressed as % of normal control values. Each deter-
mination is based on four to ten different samples of three separate 
experiments: Experiment 1-primary cultures; Experiments 2 and 
3-second passage cultures. 
*Within experiment comparison between affected and normal or 
treated cells, p < 0.001, t-test. TKl and SV8-cells infected with vec-
tors NTK-BG-Al and NSV-BG-A8 having the rat GUSB eDNA under 
the control, respectively, of the thymidine kinase and SV-40 promot-
ers (Wolfe eta!., 1990). 
mouse phosphoglucokinase-1 promoter (Fig. 14-32). In 
the affected cells, the ASB activity was only 5%-10% of 
normal, but, following transduction, there was a hun-
dredfold increase in enzymatic activity. Restoration of 
ASB activity resulted in a remarkable decrease in the 
storage of dermatan sulfate, the GAG that accumulates 
in the MPS VI RPE and other tissues. 
In vivo correction of RPE disease in the MPS VII mouse. 
The MPS VII mouse model has been used extensively to 
explore different treatment modalities aimed at correct-
ing the lysosomal enzyme deficiency, and arresting or re-
versing the pathologic sequela. Transgenic MPS VII 
mice that overexpress the human GUSB eDNA in a het-
erozygous manner show complete reversal of the stor-
age disease (Kyle et al., 1990). Retroviral vectors also 
have been used to transduce enzyme deficient hema-
topoietic stem cells or fibroblasts with the normal GUSB 
eDNA, followed by transplantation of these cells into 
MPS VII mice. Treatment results in variable degrees of 
tissue-specific correction of the disease phenotype, but 
there have been no reports of the correction of the ocu-
lar lesions (Wolfe et aL, 1992; Marechal et al., 1993; 
Moullier et aL, 1993). In regards to the eye, the most 
dramatic correction of the RPE disease in vivo has been 
effected by the adenoviral-mediated transfer of the hu-
man GUSB eDNA to ocular tissues following the in-
travitreal injection of the viral vector. In short-term ex-
{ 
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FIGURE 14-33. Cell layer GAGs in normal, MPS VII-affected, and 
vector-treated affected cells (MPS VIVfK-1, MPS VII/SV-8) following 
a 72-hour labeling period (pulse) with 35SO 4, or after a 24-hour chase. 
The two vector constructs were similar except for the internal pro-
moter driving the rat GUSB eDNA: TK-1 = herpes simplex thymidine 
kinase promoter, SV-8 simian virus 40 promoter (see 'X1olfe et al., 
1990, for details). In the MPS VII-untreated cells, newly synthesized 
radio-labeled GAGs (heparan sulfate and chondroitin sulfate) accu-
periments that lasted up to three weeks, reversal of the 
RPE storage began after one week, and, by three weeks, 
the MPS VII RPE was indistinguishable from normal (Li 
and Davidson, 1995). It is not clear from these studies 
if the adenoviral-vector-mediated eDNA transfer direct-
ly corrected the affected RPE cells, or whether cells lo-
cated outside the RPE-photoreceptor interface were 
corrected, and secreted GUSB enzyme that diffused into 
the subretinal space and cross-corrected the diseased 
RPE. Another issue not established from these studies is 
the duration of correction. Since adenoviral vectors do 
not stably integrate into the host cell's genetic material, 
it is likely that long-term stability of expression will not 
occur, thus necessitating repeated treatments. 
These studies indicate the feasibility of using vector 
mediated eDNA transfer to correct inherited defects of 
the RPE. In vitro, there is high efficiency of transduction 
of RPE cells, and the retroviral-vector-corrected cells 
show stable and long-term expression of the transferred 
eDNA (J. Ray, unpublished). In vivo, the recent studies 
using adenoviral vectors are extremely encouraging, 
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mulate in the cell layer at the end of the 72-hour pulse and remain el-
evated after a 24-hour chase period. In contrast, the vector-treated 
cells have normal levels of GAGs in the cell layer at the two time pe· 
riods examined. Enzyme digestion and deamination indicates that the 
increased radioactivity in the dermatan sulfate/chondroitin sulfate 
peak of the MPS VII cells is only in chondroitin sulfate. (Reprinted 
from Aguirre and Stramm, 1991.) 
and illustrate the possibilities of gene therapy for the 
treatment of diseases of the RPE and other posterior seg-
ment structures. Some of the issues of gene therapy in 
the RPE have been discussed previously (Aguirre and 
Stramm, 1991). 
RPE LIPOIDAL EPITHELIOPATHY 
Aging Monkey 
We and others have noted the presence of clusters of yel-
low flecks and dots present in the foveomacular region 
of aged rhesus monkeys that are maintained in long-
term toxicologic studies (Fine and Kwapien, 1978; Bell-
hornet al., 1981). These abnormalities have been de-
scribed clinically as "pigmentary abnormalities of the 
macula" or "lipoidal degeneration" and represent a 
common aging response of the rhesus monkey RPE. 
Similar lesions have been described in cynomolgus mon-
keys (Feeney-Burns et al., 1981). In the rhesus monkey, 
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FIGURE 14-34. Scanning densitometer tracings of 35S04_labeled RPE 
cell layer GAGs after conrinuous labeling for 72 hours or after a 24-
hour chase period. Each densitometer tracing represents the cell layer 
GAGs of one culture of normal, MPS VII-affected, or TK 1-vector-
treated affected cells (MPS VII-TKl) for each labeling period. The 
markers indicate where the different GAGs run on the scan. The MPS 
VII-affected RPE shows two prominent peaks of radioactivity con-
sisting of HS and a DS/CS doubler. After the 24-hour chase period, the 
levels of radioactivity decrease, but never approximate those of the 
normal or treated cells. (Reprinted with modification from Stramm et 
a!., 1990.) 
the lesions are found in both males and females, and ap-
pear to increase in severity with aging. The mildest form 
is characterized by a slight unevenness in macular pig-
mentation. Later, the macula has a finely stippled or a 
salt-and-pepper appearance. In the most severe form, 
the foveomacular region has variable numbers of yel-
lowish flecks (hypopigmented spots) which result in loss 
of the foveal reflex (Bellhorn et al., 1981 ). Fluorescein 
angiographic studies have reported conflicting findings. 
One study indicates that the hypo pigmented spots result 
in window defects visible on angiography; the window 
effect being caused by vacuolization of individual RPE 
cells (Fine and Kwapien, 1978). A second study has not 
been able to confirm these findings, and no association 
between the location and extent of the hypopigmented 
spots and angiographically visible fluorescent foci has 
been established (Bellhorn et al., 1981). These foveo-
macular pigmentary abnormalities cause no impairment 
of function as assessed by retinal testing with elec-
troretinography and visual evoked responses (Bellhorn 
et a!., 1981). Morphologically, the affected RPE cells 
and adjacent photoreceptors remain intact (Fine and 
Kwapien, 1978; Fine, 1981; Aguirre and Bellhorn, un-
published). 
In glutaraldehyde/osmium-fixed retinas embedded in 
plastic, light microscopic abnormalities are readily ap-
parent in some RPE cells located in the foveomacular re-
gion. The affected cells contain light brown to dark 
brown inclusions which, when numerous, completely 
fill the cell. These abnormalities are extremely difficult 
to detect in eyes that are conventionally fixed, embed-
ded in paraffin, and sectioned at 5-6 1-Lm. By electron 
microscopy, the affected RPE cells accumulate intracy-
toplasmic inclusions (Fine and Kwapien, 1978; Fine, 
1981; Aguirre and Bellhorn, unpublished). The vacuoles 
have a distinct limiting membrane, and, in most cases, 
have low electron density and a homogeneous appear-
ance; in some cells, the inclusions are electron lucent and 
empty (Fig. 14-35). When few in number, they usually 
are located basally. As their number increase, the inclu-
A 
B 
FIGURE 14-35. Macular RPE of an aged rhesus monkey. Upper panel 
(A) shows an RPE cell (right of vertical arrow) whose cytoplasm is full 
of lipoidal inclusions of varying electron density. The cell on the left is 
unaffected, and contains melanin granules and lipofuscin and melano-
lipofuscin inclusions. The lower panel (B) shows that the lipoidal in-
clusions are homogeneous (open star) or vacuolated ( * ). BM = Bruch"s 
membrane. Magnifications: upper panel X3,500; lower panel 
X8,600. (Aguirre and Bellhorn, unpublished.) 
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sions are located in the basal and central zones, often in 
close proximity to lysosomal andlor lipofuscin granules. 
The lipid origin of these inclusions has been confirmed 
by using osmium tetroxide fixation for electron mi-
croscopy, or glutaraldehyde fixation prior to cryosec-
tioning and oil red 0 staining (Fine, 19 81). It is likely 
that these lipid inclusions have a similar origin to those 
identified in the RPE of human eyes (El Baba, et al., 
1986). 
Congenital Stationary Night Blindness {CSNB) 
in the Dog 
Lipoidal epitheliopathy also has been described in the 
RPE of Swedish briard dogs having congenital night 
blindness (Narfstrom et al., 1994 ). The disease, initial-
ly described as a stationary disorder analogous to hu-
man CSNB, is now considered to have a progressive 
component (Narfstrom et al., 1989b; Wrigstad, 1994). 
In general, affected dogs have an ERG of normal wave-
form, but showing a marked diminution of the response 
amplitudes, similar to a "Riggs-type" ERG in man. The 
ERG recorded under DC conditions shows complete ab-
sence of the a-, b-, and c-waves, with the latter wave-
form being replaced by a very slow negative potential 
which develops when the stimulus intensity is greater 
than 3 log units above the normal b-wave threshold. 
The authors interpret the abnormalities in the a- and b-
waves as representing a delay in rod phototransduction, 
while the lack of a c-wave was ascribed to the morpho-
logic abnormalities identified in the RPE (Nilsson et al., 
1992). 
Microscopic examination of the RPE showed the 
presence of large inclusions in the central and midpe-
ripheral tapetal regions in dogs as early· as 3.5 months 
of age. By light microscopy, the inclusions are single to 
multiple; depending on the fixative used, they are vac-
uolated or appear homogeneous and stain intensely 
with crystal violet or other lipid stains (R. Riis, person-
al communication, 1995). Ultrastructurally, the inclu-
sions are electron lucent vacuoles with a more homoge-
neous cortex which often contains membranous debris 
(Wrigstad et al., 1992; 1994). Unlike the lipoidal inclu-
sions found in the aging monkey RPE, a single limiting 
membrane was absent or not distinct in some of the vac-
uoles. With aging, the inclusions increase in number and 
are found in the peripheral RPE cells. The striking fea-
ture of some of the lipid inclusions is their immense size 
(Fig. 14-36). 
At this time, the association between the lipoidal 
changes in the RPE and the primary photoreceptor de-
fect is unknown. That this interesting RPE abnormality 
FIGURE 14-36. Nontapetal RPE of adult briard dog with congenital 
stationary night blindness. Note the extremely large and homoge-
neous lipid inclusion(*) present in the RPE which dwarfs the cetl nu-
cleus (N). The retina is artifactually detached. Magnification X 5,200. 
(Photograph courtesy of Dr. Ron Riis.) 
is not an incidental finding is demonstrated by the pres-
ence of similar RPE lesions in unrelated briard dogs with 
CSNB, both in France and the United States. However, 
the causal association between the RPE and photore-
ceptor pathology is not dear. The ERG results indicate 
a widespread transduction disorder of all phororecep-
tors. In contrast, the RPE lipid storage, although promi-
nent, is not present uniformly in all cells, and the sever-
ity of the RPE pathology and photoreceptor dysfunction 
are not correlated. 
RPE AUTOFLUORESCENT INCLUSION EPITHELIOPATHY 
Retinal Pigment Epithelial Dystrophy (RPED} 
Central progressive retinal atrophy (CPRA) is a specific 
pigment epithelial dystrophy recognized in several 
breeds of dogs (Parry, 1954; Aguirre and Laties, 1976), 
which is now termed retinal pigment epithelial dystro-
phy (RPED) (Bedford, 1984). Ophthalmoscopically, the 
disease is characterized by the accumulation of irregu-
lar foci of light brown pigment over the tapetal zone; 
with rime, these foci increase in size and become dis-
tributed throughout the tapetal fundus (Plate 14-VII). In 
the end stages of the disease, the pigmentation decreas-
es or forms dusters around the margins of foci of reti-
nal atrophy. 
Using conventional histologic methods, the earliest 
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FIGURE 14-37. Retinal pigment epithelial dystrophy (RPED) in the 
dog. (A) In the early stages of the disease, there is focal hypertrophy 
of the RPE (arrowhead) with accumulation of granular light brown 
material in the cytoplasm. (B) This material is intensely autofluores-
cent (white arrow). Note that the rest of the RPE layer is normal. (C) 
With time, more cells in the monolayer become diseased (white ar-
rowheads). Opposite the hypertrophied cells, the photoreceptor inner 
and outer segments are disoriented and compressed. The outer and in-
ner nuclear layers (ONL and INL) show normal levels of autofluo-
rescence for fixed tissues. Magnifications: (A) and (B) X280; (C) 
X225. 
recognizable lesion is in the RPE. Individual cells be-
come hypertrophied and accumulate a light brown 
granular material in the cytoplasm. Opposite the hy-
pertrophied cells, the photoreceptor outer segments are 
shortened. Gradually, the focal lesion spreads in the 
RPE monolayer, and more cells become hypertrophied 
(Fig. 14-37). In the end stages of the disease, the hyper-
trophied RPE cells form multicellular cell nests; at this 
time, there is focal degeneration of the photoreceptors 
followed by complete retinal degeneration with in-
traretinal migration of non-melanin-containing cells. 
Fluorescent microscopy of unstained retinal sections in-
dicates that the diseased RPE cells, either located on 
Bruch's membrane or migrating intraretinally, contain a 
bright autofluorescent lipopigment similar to ceroid or 
lipofuscin (Fig. 14-37B, C). Recent studies reported in 
abstract form suggest that the pigments that accumulate 
in the disease vary by breed, and differ from those that 
accumulate in the aging human RPE in that they are the 
result of peroxidation of rod outer segment lipids (Wat-
son and Bedford, 1992; P. Watson, personal communi-
cation, 1993). 
Most current studies of RPED have been carried out 
in the briard dog breed in the United Kingdom (Bedford, 
1984; Lightfoot, 1988) (Note that RPED differs from 
the CSNB, which also is reported in briards.). These 
have demonstrated that rod outer segment renewal is 
normal, as is acid phosphatase activity in the RPE. In 
contrast, affected dogs are hypercholesterolemic and 
systemically deficient in vitamin E and taurine (P. Bed-
ford, personal communication, 1996; Watson et a!., 
1993). 
The clinical and histologic features of RPED are sim-
ilar to vitamin E deficiency retinopathy in dogs, either 
naturally acquired (Hayes eta!., 1970) or produced ex-
perimentally (Riis eta!., 1981). In all three diseases, the 
RPE cells become hypertrophied and accumulate lipo-
fuscin inclusions. In the experimental deficiency, how-
ever, lipofuscin accumulation and RPE hypertrophy oc-
cur after there is the beginning of photoreceptor outer 
segment degeneration visible by electron microscopy, 
and the disease course is much more rapid (Riis et a!., 
1981). This suggests that the target cell for the disease 
may be the photoreceptor, even though the most dra-
matic manifestation of the disease is in the RPE. 
The similarities between RPED and vitamin E defi-
ciency may explain its unique geographic distribution. 
The disease was once prevalent in the United States, but 
now is extremely rare, and only sporadic cases are iden-
tified. In Western Europe, particularly the United King-
dom, by contrast, the disease has had a very high preva-
lence until recently, and many breeds of dogs have been 
affected. Because of the possibility that RPED is associ-
ated with antioxidant deficiency, the disease frequency 
in young dogs has been markedly reduced with the 
widespread use of vitamin E supplementation (P. Bed-
ford, personal communication, 1996). It is not clear at 
this time, however, whether the disease represents a 
strictly nutritional deficiency, or is an inherited defect 
that becomes manifested clinically by inadequate diets. 
296 INHERITED AND METABOLIC DISORDERS 
Equine Motor Neuron Disease (EMND) 
A spontaneous neuronopathy has been recently identi-
fied in adult horses which bears a striking resemblance 
to the sporadic form of amyotrophic lateral sclerosis of 
man (Cummings eta!., 1990). The disease is a progres-
sive degeneration of motor neurons of the spinal cord 
and brainstem which results in muscle atrophy, weak-
ness, and wasting; it is generally fatal. Studies have sug-
gested an association between vitamin E deficiency and 
EMND, since affected animals have been found to have 
marked decreases in plasma vitamin E levels (Divers et 
a!., 1994), and they have demonstrated ceroid lipopig-
ment accumulation in the endothelial cells of small ves-
sels in the spinal cord (Cummings eta!., 1995). 
Characteristic lesions of the RPE have been found in 
most animals with clinical abnormalities indicative of 
EMND; in all cases, the ocular abnormalities have al-
ways been found in association with the neurologic dis-
ease. Fundus examination reveals a horizontal linear or 
mosaic pattern of pigmentation, located either close to 
the optic disc or throughout the fundus. These lesions 
are bilateral, but may vary in severity between the two 
eyes (Riis et al., 1995). The fundus abnormalities are 
the result of accumulation of an autofluorescent lipopig-
ment within hypertrophied RPE cells. Initially, the 
hypertrophied cells occur in foci with no apparent 
photoreceptor disease. Later, there is degeneration of 
the photoreceptor cells and inner retinal layers, and 
macrophages accumulate in the interphotoreceptor 
space and migrate intraretinally. Autofluorescent lipo-
pigments are found in the hypertrophied RPE and in 
macrophages. By electron microscopy, the RPE lipopig-
ments are typical of lipofuscin and ceroid (Fig. 14-38) 
(Cummings et al., in press; R. Riis, per·sonal communi-
cation, 1995) 
Neuronal Ceroid Lipofuscinosis (NCL) 
The neuronal ceroid lipofuscinoses in man are a group 
of diseases divided into distinct syndromes based on 
clinical and pathologic criteria; in general, four syn-
dromes have been recognized (infantile, late infantile, 
juvenile, and adult), and each has a complex of epo-
nyms. Although the diseases have a broad spectrum of 
neurologic abnormalities, the common denominator is 
the accumulation of autofluorescent lipopigments in 
neurons and other cells (Jolly and Palmer, 1995). Except 
for the infantile form of the disease, which is caused by 
mutations in the palmitoyl protein thioesterase gene, the 
molecular basis of NCL is unknown (Vesa et al., 1995). 
The same diversity of clinical disease and ocular abnor-
malities also occurs in animals with NCL (Aguirre eta!., 
FIGURE 14-38. RPE cell from horse affected with equine motor neu-
ron disease (EMND). Melanin granules and numerous lipofuscin {ar-
rowhead) and ceroid (open arrow) inclusions are present in the cyto-
plasm. Magnification X8500. (Photograph courtesy of Drs. R. Riis 
and J. Cummings.) 
1986; Jolly and Palmer, 1995; Jolly et al., 1994 ). A com-
mon clinical manifestation in both man and animals is 
the presence of blindness, which occurs at approxi-
mately the same time as the clinical syndrome with 
which it is associated. With some exceptions (see be-
low), the blindness is cortical in origin, since photore-
ceptor structure and function generally are preserved. 
In sheep, an early adult onset, acute form of NCL has 
been described. Animals develop normally for several 
months after birth, and then show progressive neuro-
logic abnormalities, visual deficits, and blindness; death 
occurs by approximately two years of age. Blindness in 
sheep is the result of a progressive degeneration of the 
photoreceptor cells, particularly the rods. In affected an-
imals, there is a marked loss of rod-mediated ERG re-
sponses until they disappear soon after one year of age; 
cone responses, on the other hand, remain normal until 
that time and decay thereafter. These functional abnor-
malities are reflected in the pathology of the retina, 
which demonstrates a progressive rod-cone degen-
erative process. The RPE remains relatively normal 
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throughout the disease, but accumulates numerous elec-
tron-dense membranous cytoplasmic structures which 
are autofluorescent. However, these inclusions are 
smaller and less numerous than elsewhere in the retina 
(Graydon and Jolly, 1984 ). Additionally, RPE function, 
as determined by the response to azide, remains normal 
even in blind, terminal animals (R. Jolly, personal com-
munication, 1984). Extensive photoreceptor degenera-
tion with preservation of the RPE also has been found 
in Devon cattle with NCL (Jolly et al., 1992). 
In contrast, most canine forms of NCL are distin-
guished by blindness of nonretinal origin (see Jolly et al., 
1994 for review). Of these, the best characterized dis-
ease is that found in the English setter which has an ear-
ly adult onset with an acute course (see Koppang, 1992 
for review). In this breed, retinal function is initially 
normal at a time when neurologic abnormalities are 
present. Thereafter, ERG responses become reduced 
(Berson and Watson, 1980; Aguirre et al., 1986), and, 
in the very late stages of the disease, the DC recorded 
ERG shows a severe depression of the responses. At this 
time, there is a decrease in amplitude and eventual dis-
appearance of the ERG c-wave, and a reduction in the 
standing potential (Nilsson et al., 1983). These findings 
suggest an impairment of RPE function. 
Retinal abnormalities associated with NCL have been 
reported in the Tibetan terrier (Riis et al., 1992), minia-
ture schnauzer (Smith et al., 1996) and Polish Owczarek 
Nizinny (Wrigstad et al., 1995) dog breeds. In Tibetan 
terriers night blindness is the primary clinical abnor-
mality recognized in young animals. In contrast, NCL 
in the Nizinny breed appears clinically similar to RPED, 
and the fundus shows the accumulation of irregular foci 
of light brown pigment over the tapetal zone which, 
histologically, reflects the storage of autofluorescent 
lipopigments in hypertrophied RPE cells . In these three 
breeds, the clinical manifestations of NCL are initially 
retinal (photoreceptor or RPE), with neurological ab-
normalities occurring later in life. 
As in humans and other animal models of NCL, 
autofluorescent lipopigment inclusions accumulate in 
the RPE cells and other retinal and CNS neurons of af-
fected English setter dogs. However, the association be-
tween neuronal lipopigment storage and cell death is 
not known. Since there is no degeneration of the retina 
or RPE cells in many different animals with this disease, 
even though significant storage is present (Neville et al., 
1980), the causal association between lipopigment stor-
age, cell dysfunction, and cell death is not clear at this 
time. This will require identification of the molecular 
defects present in these different diseases, and charac-
terization of the biochemical abnormalities resulting 
from the gene defect(s). 
MACULAR ABNORMALITIES AND DRUSEN 
IN MONKEYS 
Macular degeneration is uncommon in the subhuman 
primate. With few exceptions, abnormalities of the mac-
ula occur sporadically, and are reported as single case 
studies. ·Attempts to determine if macular degeneration 
occurs naturally in primates have resulted in surveys of 
monkey colonies (Stafford, 1974; El-Mofty et al., 1978; 
Nicolas et al., 1996), the most extensive of these under-
taken at the Cayo Santiago colony, a part of the 
Caribbean Primate Center (El-Mofty et al., 1978; 1980; 
Engel et al., 1988; Dawson et al., 1989). In their initial 
survey, El-Mofty and colleagues (1978) reported two 
types of macular anomalies which were age related and 
affected approximately half of the 105 animals exam-
ined: (a) a macular pigmentary disorder showing various 
degrees of irregularity in the distribution and intensity of 
pigmentation, and (b) multiple discrete small white spots 
that mainly clustered in the paramacular area. The pig-
mentary abnormalities probably are the lipoidal epithe-
liopathy described in a preceding section, while the para-
macular white spots were interpreted by the authors as 
drusen. A repeat study of a larger group of animals con-
firmed the previous observations and found that over 
80% of old animals had macular lesions (El-Mofty et al., 
1980). However, some young animals one to three years 
of age also showed similar lesions of equal severity, sug-
gesting a heritable component to the disorder. A separate 
and independent survey of this colony has been under-
taken, and confirmed the presence of macular drusen 
which, histologically, are nearly identical to similar le-
sions found in the human eye. Although this limited sam-
ple did not show any animals with the exudative form of 
AMD or disciform scars (Engels et al., 1988), a larger 
sampling reported older animals with end-stage disci-
form changes (Dawson et al., 1989). 
In a study by Feeney-Burns and colleagues ( 1981), the 
authors examined the retinas of cynomolgus monkeys 
with macular abnormalities visible by ophthalmoscopy 
or fluorescein angiography. Lipoidal epitheliopathy, 
misshapen foveal depressions, RPE depigmentation, 
and exudative foci underneath the RPE were found. Sur-
prisingly, morphologic examination of the macular re-
gion of animals considered clinically normal showed 
retinal pathology limited to the macular region. These 
consisted of degeneration of parafoveal cones, balloon-
ing and disarray of foveolar cone outer segment disc 
membranes, and accumulation of lamellar, osmiophilic 
material in the inner and outer segments. The authors 
emphasized the importance of thoroughly characteriz-
ing the normalcy of primate populations before their use 
in experimental studies. 
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Drusen have been reported in monkeys, either limit-
ed to the macular region, or uniformly distributed 
throughout the fundus (Barnett et al., 1972; Stafford, 
1974; El-Mofty et al., 1980; Ishibashi et al., 1986). The 
histologic appearance of the lesions is quite characteris-
tic, and similar to comparable abnormalities in man. As 
noted previously, the incidence of macular and para-
macular druse increases with aging. Generalized drusen 
of the fundus have been found in baboons and rhesus 
monkeys, usually at a young age, suggesting that these 
lesions may be present congenitally or develop in the 
perinatal period. They occur as large, single or multiple 
nodules which are overlaid by an extremely thin and at-
tenuated RPE. Other than disorientation of the apposed 
photoreceptor cells, there is surprisingly minimal patho-
logy of the retina (Barnett et al., 1972; Aguirre, unpub-
lished). 
A bilateral macular degeneration associated with 
widespread outer retinal disease has been reported in a 
colony of captive reared Guinea baboons (Vainisi et al., 
1974). In the propositus, the maculae were atrophic, 
with a reticular yellow metallic appearance, and promi-
nent window defects were evident on angiography 
(Plate 14-VIII). The RPE and retina were absent in the 
macular region; more peripherally, there was photore-
ceptor degeneration with RPE preservation. Additional 
studies on animals from this colony have shown that the 
disease is likely to be hereditary, but the mode of inher-
itance has not been established. In young animals, the 
initial clinical abnormalities are restricted to the macu-
la (subtle depigmentation in the fovea surrounded by a 
hyperpigmented ring); histologically, the RPE is normal, 
but disease is present in the photoreceptors and is more 
widespread. There is initially degeneration of parafoveal 
rods and cones which subsequently spreads to involve 
those photoreceptors in the equator and periphery. In 
animals with advanced macular degeneration, there is 
extensive degeneration and loss of the photoreceptor 
and outer nuclear layers in the equator and periphery 
(Tso et al., 1983; Santos-Anderson et al., 1983). Unfor-
tunately, a colony of this potentially important animal 
model for human retinal disease is no longer extant. 
ORNITHINE-o-AMINO TRANSFERASE 
DEFICIENCY IN CATS 
Deficiency of the mitochondrial matrix enzyme or-
nithine-5-amino transferase (OAT) causes a retinal de-
generation in man and cats. In man, the disease is 
termed gyrate atrophy of the choroid and retina because 
of the characteristic fundus lesions. In contrast, cats 
with OAT deficiency have a generalized retinal degen-
eration (Plate 14-IX) that is clinically indistinguishable 
from that present in animals affected with PRA, the 
group of primary photoreceptor degenerative diseases. 
In cats the disease has been found sporadically, and is 
characterized by hundredfold elevation in plasma or-
nithine levels with overflow ornithinuria (Valle et al., 
1981; 1983; Rosenzweig et al., 1990). This results from 
deficiency of OAT in tissues, and enzyme deficiency is 
confirmed in cultured fibroblasts. A suggestion of auto-
somal recessive inheritance is based on the finding that 
presumably heterozygous animals have reduced OAT 
activity levels that are intermediate between affected 
and normal cats (Giger, personal communication, 
1995). In one animal, OAT was pyridoxine responsive, 
but long-term oral supplementation with this vitamin 
did not affect the progression of retinal degeneration 
(Aguirre, unpublished). Histologic examination of the 
retina shows complete atrophy of the RPE and pho-
toreceptor cells, and end-stage retinal degeneration (Fig. 
FIGURE 14-39. Light (A and B) and electron (C) micrographs of the 
tapetal retina from an adult cat with ornithine-8-amino transferase de-
ficiency. (A) Retina in the posterior pole shows loss of RPE and pho-
toreceptor layers, with preservation of inner retina (INL, IPL, NFL). 
(B) Tapetal region (TL) showing a very thin and gliotic retina with a 
prominent ganglion cell. (C) Unidentified neuron (N) surrounded by 
prominent glial fibers (G) is located adjacent to the tapetum lucidum 
(TL). Magnifications: (A) and (B) X400, (C) X9,600. (Reprinted from 
Valle et al., 1981.) 
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14-39) (Valle et al., 1981). Such extensive atrophy of the 
outer retina is unusual for retinal-degenerative disorders 
in cats or other animals. 
THE RPE AND ECTOPIC PHOTORECEPTOR NUCLEI 
Subretinal displacement of photoreceptor nuclei has 
been found in many different animal species. In the rat, 
the displacement reflects a general mechanism of cell 
loss that is influenced, to some extent, by aging and en-
vironmental exposure to high ambient light intensities 
(Lai eta!., 1978; Lai 1980). A similar process occurs in 
humans and has been associated with age-related de-
generative disorders of the eye, diabetes, or systemic in-
fections (Lai et al., 1982). In most cases, the distinct cy-
tologic characteristics of the photoreceptor nuclei help 
to distinguish them from the phagocytic cells that in-
vade the sub retinal space during the degenerative phase 
of primary photoreceptor diseases (see "Photoreceptor 
degeneration, RPE pigmentation, and interphotorecep-
tor space phagocytic cells," above). 
The presence of ectopically located photoreceptor nu-
clei in the subretinal space is supposed to represent two 
FIGURE 14-40. Ectopically located cone nucleus (CN) adjacent to the 
retinal pigment epithelium (PE) in an adult dog with hereditary cone 
degeneration ( cd). The ectopic nucleus is surrounded by a rim of cy-
toplasm, and indents the a pica! border of the PE, bringing the apical-
ly located melanin granules closer to the basal PE surface and Bruch's 
different cell death mechanisms: in situ death followed 
by displacement, and the outward movement of pho-
toreceptors with their subsequent death in the subreti-
nal space (Lai eta!., 1982). Recent studies in dogs with 
inherited cone degeneration question the loss of viabili-
ty of the ectopically located photoreceptor cell nuclei, 
particularly cones (Gropp eta!., 1996). 
We have previously identified a canine model for rod 
monochromatism in man (Aguirre and Rubin, 1974; 
1975). The disease was initially termed hemeralopia, 
but, in order to prevent etymological controversy, the 
name and gene locus identification were changed to 
cone degeneration (Long and Aguirre, 1991). Cone de-
generation (cd) is a rare, autosomal recessive disorder 
found originally in the Alaskan malamute breed, and 
characterized by specific functional and structural ab-
normalities limited to the cone photoreceptors. The dis-
ease is unique in being the only model for selective cone 
degeneration in man. In the cd retina, cones become dys-
functional early in life, show disorganization and loss of 
outer segments, and accumulate 100 A neurofilament 
bundles in the inner segment and perinuclear cytoplasm; 
degeneration of cones occurs subsequently. 
An unusual feature of cd is the manner in which cone 
membrane (BM). The ectopic nucleus is surrounded by the apical mi-
crovilli of the PE {open arrows). Note the distinct separation between 
the cytoplasmic membranes of the PE and the ectopic cone nucleus 
(black/white arrows). Magnification X 10,500. (Reprinted from 
Gropp et al., 1996.) 
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FIGURE 14-41. Paired PNA fluorescence and Nomarski (A, C and B, 
D) photomicrographs of the cd retina from an adult affected dog. 
Groups of PNA-positive cone somata are clustered ectopically in the 
subretinal space (A) (open arrow). Some cells extend PNA positive 
processes (B) (arrow) proximally to the external limiting membrane 
(marked by arrowheads inC and D). Distinct cone matrix sheaths are 
still present (A) (arrow). Artefactual detachment of the retinal pigment 
epithelial layer accentuates the ectopically located cone nuclei. Mag-
nifications: (A) and (C) X250; (B) and (D) X750. (Reprinted from 
Long and Aguirre, 1991.) 
loss evolves. Unlike other models of photoreceptor de-
generation, where nuclear pyknosis and ~poptotic cell 
death follow disease and degeneration of the outer and 
inner segments (Chang et al., 1993; Portera-Cailliau et 
al., 1994 ), this process does not occur, at least initially, 
in the cd retina. Diseased cones undergo slow extrusion 
of the nucleus into the inner segment, displacement into 
the interphotoreceptor space, and final placement adja-
cent to the RPE (Fig. 14-40). In this position, the ec-
topically located nuclei indent the RPE surface, but 
cause no further response (Gropp et aL, 1996). Cone ex-
trusion also occurs in complete typical rod monochro-
matism in man, the disease for which cd serves as an an-
imal model {Larsen, 1921; Harrison et al., 1960; Falls 
et al., 1965). In the retinas of humans affected with this 
disorder, there is loss of cones as well as the presence of 
ectopic cone nuclei which are located in the inner seg-
ment, in the interphotoreceptor space, and adjacent to 
the RPE (Falls et al., 1965). 
Examination of cd-affected retinas embedded in plas-
tic and sectioned at 1 f.1m suggests that the ectopic cone 
---
FIGURE 14-42. Brightfield (Al' B1 ) and combined brightfield/epipo-
larization (Bz) photomicrographs of the cd retina from a young af-
fected dog hybridized with 3H-labeled antisense human red/green 
cone opsin cRNA probe. The ectopically located cone nuclei (arrow-
heads) are located adjacent to the retinal pigment epithelium (Ap *; 
see B1 for higher magnification), and have an accumulation of silver 
grains in the perinuclear cytoplasm. The remaining cones in the pho-
toreceptor layer (arrows, A11 B1) have silver grains that cluster in the 
perinuclear cytoplasm or the proximal inner segment. The intensity of 
the hybridization signal in all cones is normal. Magnifications: (A1) 
X800; (B1 ) and (B2 ) X1000. (Reprinted from Gropp et al., 1996.) 
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nuclei are separated from the photoreceptor layer. How-
ever, in thicker sections (10 J.Lm) reacted with peanut ag-
glutinin (PNA) lectin to identify the extracellular cone 
matrix domains, some of the subretinal nuclei appear to 
be connected to the external limiting membrane, and, in 
some cases, form cellular aggregates in the subretinal 
space (Fig. 14-41-Long and Aguirre, 1991). Addition-
ally, in situ hybridization using a red/green cone pigment 
cRNA probe indicates normal cone opsin gene expres-
sion (Fig. 14-42). Based on the presence of cone pigment 
mRNA transcripts, and immunoreactivity (using cone-
specific antibodies) of intensity equal to that found in 
normally placed cone cells, we consider these ectopic 
cone nuclei viable (Gropp et al., 1996). With aging, 
there is progressive loss of cone nuclei from their nor-
mal position in the photoreceptor layer, and the oldest 
retina examined had the greatest number of ectopic 
cone nuclei located at the level of the RPE. Whether the 
ectopically located cone nuclei eventually degenerate or 
remain viable is not known at this time. However, their 
position adjacent to the RPE monolayer fails to elicit 
any histologically evident cellular response. 
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